Podcasts about Institutional review board

Professor Stanley K. Ridley is a Professor of Management at Drexel University's Lebow College of Business. He holds a Doctorate and Masters in International Relations from Duke University and an International MBA from Temple University. Additionally, Professor Ridgley has studied at Moscow State University and the Institut de Gestion Sociale in Paris. He is a former military intelligence officer who served in West Berlin and near the Czech-German border during the Cold War, where he received the George S. Patton Award for Leadership from the 7th Army NCO Academy. Professor Ridgley lectures throughout the United States and internationally. He serves as Drexel's faculty sponsor for Turning Point USA, serves on Drexel's Faculty Senate, and on Drexel's Institutional Review Board.  He is a frequent contributor to national media and is author of Brutal Minds- The Dark World of Left-Wing Brainwashing in Our Universities. He is to talk about was going today on our college campuses and universities. Intro & Outro Music: Crown Heights - Richard Madnick Order a Copy of Brutal Minds: https://www.amazon.com/dp/163006226X/?bestFormat=true&k=brutal%20minds%20book&ref_=nb_sb_ss_w_scx-ent-pd-bk-d_de_k0_1_12&crid=1GJX05CA5NZL7&sprefix=brutal%20minds Professor Ridgley's website: https://brutalminds.com/

In this thought-provoking episode of The Dude Therapist, Eli Weinstein sits down with Dr. Judy, a renowned clinical and forensic neuropsychologist, to dive deep into the power of self-talk and how our attachment styles shape our present-day behaviors. Dr. Judy sheds light on the long-lasting impact of past experiences, offering insights into why we act the way we do and how balanced thinking can lead to transformative healing—at any age. Together, they tackle the often misunderstood world of disorganized attachment, uncover practical coping strategies, and provide actionable tips to turn those nagging negative thoughts into empowering positive actions. Whether you're seeking healing or understanding, this episode has something for everyone! BIO: Dr. Judy Ho, Ph. D., ABPP, ABPdN, is a triple board certified and licensed Clinical and Forensic Neuropsychologist, a tenured Associate Professor at Pepperdine University, and a published author, penning “Stop Self-Sabotage,” published by HarperCollins in August 2019; a book detailing a scientifically driven six-step program which has been translated into 7 additional languages around the world. Her second book, which she co-authored with Max Dubrow, entitled "I'll Give it to Your Straight-ish: What Your Teen Wants You to Know," is published by Flashpoint and contains Dr. Judy's evidence-based tips to help parents raise healthy and resilient teenagers. Dr. Judy's third book, The New Rules of Attachment, which focuses on healing insecure attachment styles at any age to optimize well-being, career, goal attainment, and relationships with family, friends, and colleagues, was published by Hachette Book Group in March 2024. Dr. Judy maintains a private practice in Manhattan Beach, CA where she specializes in comprehensive neuropsychological assessments and expert witness work. She regularly appears as an expert psychologist on television, podcasts, and radio and contributes to other media, including print and electronic periodicals. She was a co-host on the syndicated daytime television talk show “The Doctors,” co-host of CBS's Face the Truth, and host of The SuperCharged Life podcast, which focuses on scientific, tangible tips for physical and mental wellness and strategies for motivation and productivity, produced by Stage 29 Podcast Productions. Dr. Judy Ho is an avid researcher and two-time recipient of the National Institute of Mental Health Services Research Award. She hosts an active research program to improve mental health care for high-need populations and is the chair of the Institutional Review Board at Pepperdine University. Her treatment approaches integrate the scientific principles of Cognitive Behavioral Therapy, Acceptance and Commitment Therapy, and Dialectical Behavioral Therapy. She often speaks at national and local events including research, clinical, and corporate conferences and workshops for organizations and schools. Dr. Judy received her bachelor's degrees in Psychology and Business Administration from UC Berkeley, and her masters and doctorate from SDSU/UCSD Joint Doctoral Program in Clinical Psychology. She completed a National Institute of Mental Health sponsored fellowship at UCLA's Semel Institute. --- Support this podcast: https://podcasters.spotify.com/pod/show/thedudetherapist/support

In this episode of Join the Docs, our ever-curious hosts, Professor Jonathan Sackier and Doctor Nigel Guest, take a deep dive into the labyrinthine world of medical research. With their signature blend of wit and wisdom, they aim to demystify the intricate processes behind drug discovery and clinical trials, making it as clear as a well-written prescription minus the totally illegible doctor's handwriting of course!How does Professor Sackier set the tone for the discussion? He compares drug discovery to dating. You have to kiss a lot of frogs before you find your prince—or in this case, your blockbuster drug! Dr. Guest, not to be outdone, quips back, "And just like dating, it can cost you an arm and a leg, but hopefully not your liver!"The  Docs delve into the various types of research, from basic science to clinical studies with a nod to the ridiculous. Ethical considerations are next on the menu, and Dr. Guest serves up a hearty helping of humour. The Docs discuss the importance of informed consent, patient safety, and the moral dilemmas that can arise, all while keeping the tone light and engaging. However, sometimes people go astray and medics are not immune; The Docs explore cases where some very naughty people did rather terrible things with publications - you won't want to miss these stories!The episode emphasises the role of curiosity and the unwavering commitment to improving patient care as the key motivators for doctors. Curiosity didn't just kill the cat, says Sackier, it also cured it! Well, metaphorically speaking, of course. They share heartwarming and hilarious anecdotes about their own experiences in the field, making the complex topic relatable and entertaining.With their infectious humour and deep knowledge, Professor Jonathan Sackier and Doctor Nigel Guest make this episode of Join the Docs a must-listen for anyone curious about the world of medical research. So grab your lab coat and stethoscope, and get ready for a rollercoaster ride through the fascinating, funny, and sometimes downright bizarre world of drug discovery and clinical trials!—--DISCLAIMER: The views and opinions expressed on Join the Docs are those of Dr. Nigel Guest, Jonathan Sackier and other people on our show. Be aware that Join the Docs is not intended to be medical advice, it is for information and entertainment purposes only - please, always take any health concerns to your doctor or other healthcare provider. We respect the privacy of patients and never identify individuals unless they have consented. We may change details, dates, place names and so on to protect privacy. Listening to Join the Docs, interacting on our social media, emailing or writing to us does not establish a doctor patient relationship.To Contact Us: For a deeper dive on this episode's issue, merchandise and exclusive content, head to www.jointhedocs.comFollow us on youtube.com/JoinTheDocs Follow us on instgram.com/JoinTheDocsFollow us on tiktok.com/JoinTheDocsFollow us on: facebok.com/JoinTheDocsFollow us on: x.com/JoinTheDocs

The news of Texas covered today includes:Our Lone Star story of the day: Dr. Merrill Matthews joins us to talk about the 2024 presidential election and we work from several of his columns that have recently appeared in The Hill, including: For Democrats, ‘Freedom' is Just Another Word for Mandate Are You Ready for ‘Kamalanomics?' What ‘Evangelicals for Harris' Gets Terribly Wrong Merrill Matthews, Ph.D., is a health policy expert and regular columnist at The Hill. He has worked with the Institute for Policy Innovation, a research-based, public policy “think tank” in the Metroplex for many years.Dr. Matthews is a past president of the Health Economics Roundtable for the National Association for Business Economics, the largest trade association of business economists. Dr. Matthews also served for 10 years as the medical ethicist for the University of Texas Southwestern Medical Center's Institutional Review Board for Human Experimentation, co-author of On the Edge: America Faces the Entitlements Cliff, and has contributed chapters to several books, including Physician Assisted Suicide: Expanding the Debate and The 21st Century Health Care Leader and Stop Paying the Crooks (on Medicare fraud).  He has been published in numerous journals and newspapers, including The Wall Street Journal, Investor's Business Daily, Barron's, USA Today, The Hill, Forbes magazine and the Washington Times. He was an award-winning political analyst for the USA Radio Network.  Dr. Matthews received his Ph.D. in Humanities from the University of Texas at Dallas.Our Lone Star story of the day is sponsored by Allied Compliance Services providing the best service in DOT, business and personal drug and alcohol testing since 1995.Listen on the radio, or station stream, at 5pm Central. Click for our radio and streaming affiliates.www.PrattonTexas.com

The International Lymphatic Disease and Lymphedema Patient Registry & Biorepository plays a crucial role in advancing lipedema research and raising awareness about the condition. Overseen by the LE&RN Board of Directors and the Institutional Review Board of Stanford University, led by Dr. Stanley Rockson, the registry aims to expand our understanding of lipedema. Participation, particularly from women with lipedema, is essential to enhance the knowledge base surrounding this disease.

Discover the secret to removing toxins with my FREE Detox Decoded Masterclass. https://hayliepomroy.com/detox   In this episode with Dr. Amanpreet Cheema, Program Director of Research Operations at the Institute for Neuro-Immune Medicine, we discuss how the experts and researchers at the Institute of Neuro-Immune Medicine effectively collaborate to translate scientific discoveries into real-world solutions for Gulf War Illness.   Research on Gulf War Illness keeps progressing, driven by our passion and dedication to serving our war veterans. Dr. Amanpreet Cheema and her team work tirelessly to discover new insights and treatments for this condition. Dr. Cheema explains the ongoing study on Bacopa monnieri, glutamate, N-acetyl cysteine, and B-cell suppression, which aims to help veterans and individuals heal not only from Gulf War Illness but also from other chronic illnesses.   Enjoy this episode? Subscribe to Power On Your Plate and leave a 5-star review.   Sign up for the 10-Day Cleanse Challenge here! https://hayliepomroy.com/cleanse   Get a FREE hard copy of the Fast Metabolism Diet book! https://hayliepomroy.com/freebook   Become a certified Fast Metabolism Health Coach NOW! https://hayliepomroy.com/fmdc   Become a member, FREE for 30 days! https://hayliepomroy.com/member   Dr. Amanpreet Cheema, PhD, is the Program Director of GWICTIC Research Operations at the Institute for Neuro-Immune Medicine. With a background in nutritional biochemistry, she focuses on identifying natural products and nutraceuticals as potential therapies for complex illnesses. Dr. Cheema oversees clinical research development and operations, having previously coordinated operations for a multi-site consortium. She also serves as vice chair on NSU's Institutional Review Board and holds an Assistant Professor position at INIM, Department of Nutrition Science. Her research aims to create profiles of complex illnesses based on nutrition and disease symptomology, facilitating patient subgrouping and identifying disease targets.   LinkedIn: https://www.linkedin.com/in/amanpreet-cheema-phd-ms-55037158/   Learn more about the Bacopa study for Gulf War Illness here: https://clinicaltrials.gov/study/NCT04927338   For more information, please contact 954-262-2870 or email GWICTIC@nova.edu.   #GulfWarIllness #clinicalresearch #Bacopamonnieri  

Discover the secret to removing toxins with my FREE Detox Decoded Masterclass. https://hayliepomroy.com/detox   In this episode with Dr. Amanpreet Cheema, Program Director of Research Operations at the Institute for Neuro-Immune Medicine, we discuss how the experts and researchers at the Institute of Neuro-Immune Medicine effectively collaborate to translate scientific discoveries into real-world solutions for Gulf War Illness.   Research on Gulf War Illness keeps progressing, driven by our passion and dedication to serving our war veterans. Dr. Amanpreet Cheema and her team work tirelessly to discover new insights and treatments for this condition. Dr. Cheema explains the ongoing study on Bacopa monnieri, glutamate, N-acetyl cysteine, and B-cell suppression, which aims to help veterans and individuals heal not only from Gulf War Illness but also from other chronic illnesses.   Enjoy this episode? Subscribe to Power On Your Plate and leave a 5-star review.   Sign up for the 10-Day Cleanse Challenge here! https://hayliepomroy.com/cleanse   Get a FREE hard copy of the Fast Metabolism Diet book! https://hayliepomroy.com/freebook   Become a certified Fast Metabolism Health Coach NOW! https://hayliepomroy.com/fmdc   Become a member, FREE for 30 days! https://hayliepomroy.com/member   Dr. Amanpreet Cheema, PhD, is the Program Director of GWICTIC Research Operations at the Institute for Neuro-Immune Medicine. With a background in nutritional biochemistry, she focuses on identifying natural products and nutraceuticals as potential therapies for complex illnesses. Dr. Cheema oversees clinical research development and operations, having previously coordinated operations for a multi-site consortium. She also serves as vice chair on NSU's Institutional Review Board and holds an Assistant Professor position at INIM, Department of Nutrition Science. Her research aims to create profiles of complex illnesses based on nutrition and disease symptomology, facilitating patient subgrouping and identifying disease targets.   LinkedIn: https://www.linkedin.com/in/amanpreet-cheema-phd-ms-55037158/   Learn more about the Bacopa study for Gulf War Illness here: https://clinicaltrials.gov/study/NCT04927338   For more information, please contact 954-262-2870 or email GWICTIC@nova.edu.   #GulfWarIllness #clinicalresearch #Bacopamonnieri  

On this episode, I will be interviewing Dr. Stanley Ridgley, author of Brutal Minds: The Dark World of Left-Wing Brainwashing in Our Universities. Dr. Ridgley is Clinical Full Professor of Management at Drexel University's LeBow College of Business. Dr. Ridgley has also studied at Moscow State University and the Institut de Gestion Sociale in Paris. He is a former Military Intelligence Officer who served in West Berlin and near the Czech-German border, where he received the George S. Patton Award for Leadership from the 7th Army NCO Academy. In addition to his teaching, Dr. Ridgley lectures widely in the United States and internationally. He is Drexel's faculty sponsor for Turning Point USA, serves on Drexel's Faculty Senate, and on Drexel University's Institutional Review Board. He is a frequent contributor to national media including Newsmax and American Greatness, and is also the highly praised faculty instructor for the course “Strategic Thinking” in the DVD series TheGreatCourses.com.--brutalminds.com--https://policecoffee.com

Dr Judy Ho has a new book entitled The New Rules of Attachment: How to Heal Your Relationships, Reparent Your Inner Child, and Secure Your Life Vision. It's one of those books which explain to us, in our therapeutic age of intense anxiety, how to stop f*****g ourselves up. Yeah, I know. These kinds of books, by “clinical and forensic neuropsychologists” like the telegenic Judy Ho, can be intensely annoying. But, as an proven expert in f*****g up one's life, I rather liked Dr Judy's arguments about “reparenting our inner child” and securing our “life vision”. And I was particularly intrigued by her theory of “Dialectical Behavioral Therapy” - a particularly wild Jungian child of Marx's parental principle of dialectical materialism.Dr. Judy Ho, Ph. D., ABPP, ABPdN is a triple board certified and licensed Clinical and Forensic Neuropsychologist, a tenured Associate Professor at Pepperdine University, and published author. She penned Stop Self-Sabotage (published by HarperCollins in August 2019), a book detailing a scientifically driven six-step program which has been translated into 7 additional languages around the world. Her second book, co-authored with Max Dubrow, titled I'll Give it to Your Straight-ish: What Your Teen Wants You to Know, was published by Flashpoint in November 2021 and contains Dr. Judy's evidence-based tips to help parents raise healthy and resilient teenagers. Dr. Judy's third book, The New Rules of Attachment, which focuses on healing insecure attachment styles at any age to optimize well-being, career, goal attainment, and relationships with family, friends, and colleagues, published by Hachette Book Group in March 2024. Dr. Judy maintains a private practice in Manhattan Beach, CA where she specializes in comprehensive neuropsychological assessments and expert witness work. She regularly appears as an expert psychologist on television, podcasts, radio, and contributes to other media including print and electronic periodicals. She was a co-host on the syndicate daytime television talk show The Doctors, co-host of CBS's Face the Truth, and host of The SuperCharged Life podcast. Dr. Judy Ho is an avid researcher and a two-time recipient of the National Institute of Mental Health Services Research Award. She teaches masters and doctoral level psychology students, hosts an active research program to improve mental health care for high-need populations, and is the chair of the Institutional Review Board at Pepperdine University. Her treatment approaches integrate the scientific principles of Cognitive Behavioral Therapy, Acceptance and Commitment Therapy, and Dialectical Behavioral Therapy. She is a sought after keynote speaker and educator for national and local events including research, clinical, and corporate conferences and workshops for businesses, organizations, and schools.Named as one of the "100 most connected men" by GQ magazine, Andrew Keen is amongst the world's best known broadcasters and commentators. In addition to presenting KEEN ON, he is the host of the long-running How To Fix Democracy show. He is also the author of four prescient books about digital technology: CULT OF THE AMATEUR, DIGITAL VERTIGO, THE INTERNET IS NOT THE ANSWER and HOW TO FIX THE FUTURE. Andrew lives in San Francisco, is married to Cassandra Knight, Google's VP of Litigation & Discovery, and has two grown children.Keen On is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit keenon.substack.com/subscribe

Translational research is now a key player in advancing studies for Gulf War Illness. In this episode, Dr. Amanpreet Cheema, Program Director of Research Operations at the Institute for Neuro-Immune Medicine, discusses how the experts and researchers at the Institute effectively collaborate to translate scientific discoveries into real-world solutions for Gulf War Illness.  Joined by Haylie Pomroy, Dr. Cheema also explores the ongoing research and initiatives addressing health issues affecting Gulf War veterans. They also discuss studies involving Bacopa monnieri, glutamate, N-acetyl cysteine, and B-cell suppression, aiming to help veterans and individuals heal from chronic illness symptoms. Dr. Amanpreet Cheema, PhD, is the Director of Office of Clinical Research at the Institute for Neuro-Immune Medicine. With a background in nutritional biochemistry, she focuses on identifying natural products and nutraceuticals as potential therapies for complex illnesses. Dr. Cheema oversees clinical research development and operations, having previously coordinated operations for a multi-site consortium. She also serves as vice chair on NSU's Institutional Review Board and holds an Assistant Professor position at INIM, Department of Nutrition Science. Her research aims to create profiles of complex illnesses based on nutrition and disease symptomatology, facilitating patient subgrouping and identifying disease targets. LinkedIn: https://www.linkedin.com/in/amanpreet-cheema-phd-ms-55037158/ —------------------------------------------------------------------------------------------ Thank you for tuning in to the Hope and Help For Fatigue and Chronic Illness Podcast. Sign up today for our newsletter.

Description: Co-host Ryan Piansky, a graduate student and patient advocate living with eosinophilic esophagitis (EoE) and eosinophilic asthma, and co-host Mary Jo Strobel, APFED's Executive Director, speak with Dr. Kathryn Peterson, MD, MSCI, a Professor of Gastroenterology at the University of Utah Health. In this episode, Ryan and Mary Jo interview Dr. Peterson about the family risk of eosinophilic gastrointestinal diseases, discussing the studies she has done, future work she is planning, and other studies of related topics. She shares that she is a parent to a patient living with an eosinophilic disorder. She hints at future research that may lead to easier diagnosis of EGIDs.   Listen in for more information on Dr. Peterson's work. Disclaimer: The information provided in this podcast is designed to support, not replace the relationship that exists between listeners and their healthcare providers. Opinions, information, and recommendations shared in this podcast are not a substitute for medical advice. Decisions related to medical care should be made with your healthcare provider. Opinions and views of guests and co-hosts are their own.   Key Takeaways: [:49] Ryan Piansky welcomes co-host Mary Jo Strobel. Mary Jo introduces Dr. Kathryn Peterson, a Professor of Gastroenterology at the University of Utah Health. Dr. Peterson specializes in diagnosing and treating diseases of the digestive system including eosinophilic esophagitis (EoE), Barrett's esophagus, and inflammatory bowel disease.   [2:00] Dr. Peterson works at the University of Utah in Salt Lake City. She co-directs an eosinophilic gastrointestinal disease clinic with Dr. Amiko Uchida. They also work closely with allergy, nutrition, and pharmacy in the clinic and are looking for additional ancillary services to come into the clinic.   [2:27] Dr. Peterson takes care of all sorts of eosinophilic gastrointestinal diseases. She works closely with Dr. Gerald Gleich, as well. Dr. Peterson is a mother of a boy living with eosinophilic disease for 10 years, so she experiences both sides of eosinophilic diseases. She loves her job.   [3:23] Familial risk refers to the risk of the disease in a patient when a family member is affected, compared to the general population. Looking at a proband (patient), is a first-degree family member (parent, sibling, or child) also affected with eosinophilic disease? Is a second-degree family member (grandparent) affected? Are cousins?   [3:58] Dr. Peterson's is trying to see if and how far out the risk for the disease goes within a family. Based on that, you can get an idea if some shared genes are involved, vs. shared environmental influence of the disease within family members. That's the idea of doing family risk studies in complex diseases; eosinophilic diseases are very complex.   [4:44] Dr. Peterson explains how she conducts a family risk study in Utah. The Utah Population Database is very helpful. The University of Utah has partnered with The Church of Jesus Christ of Latter-day Saints for large genealogical pedigrees that allow tracking disease through expanded pedigrees, with privacy and security limitations.   [5:24] It's necessary to clarify physician coding to make sure it's realistic and coded appropriately so that results are believable. It's very hard to recruit family members. Dr. Peterson feels extremely blessed to live in that area. The families are generous and giving. She also believes all eosinophilic families are generous.   [6:34] The farther out you can identify the risk for disease, the more likely you will find a common gene that could be implicated in disease risk or onset. If the disease is tracked in extended relatives, it implies a shared gene more than a shared environmental risk. If the disease is isolated within nuclear families, it may indicate an environmental risk.   [7:39] In doing familial research, Dr. Peterson is trying to develop a risk score. People are getting pretty good at diagnosing EoE, but Dr. Peterson would not say that the non-EoE EGIDs are well-established or well-diagnosed. They are missed commonly and often. To have a risk score from the extent of the disease in a family is helpful.    [8:12] Dr. Peterson notes that studies of cancer risk in extended families have established cancer risk scores and related screening that is needed.   [8:43] Dr. Peterson coauthored a paper in November 2020 about the familial risk of EoE, published in the Clinical Gastroenterology and Hepatology Journal. She and her colleagues looked at nuclear families. They were looking for how many members of the nuclear family of an EoE patient have esophageal eosinophilia. [9:28] They used a questionnaire on allergies, food allergies, and symptoms. They pulled in around 70 first-degree family members and scoped them for eosinophilia, pulled the records on the rest of the family members if they had been scoped, and assessed the risk for eosinophilia.   [9:51] Including the records, and assuming that everyone who hadn't had an endoscopy was negative, they found the risk for esophageal eosinophilia in first-degree family members was 14%, bordering on the familial risk for celiac disease. It's probably higher since they assumed anyone who hadn't been scoped didn't have eosinophilia.   [10:19] They called it esophageal eosinophilia, because the guidelines for diagnosing EoE suggest that the patient must complain of symptoms, and these family members did not have symptoms. It was interesting to find this high prevalence of eosinophilia in the nuclear family members of EoE patients. They had a higher risk of allergy, as well.   [11:14] Dr. Peterson explains the differences between esophageal eosinophilia and eosinophilic esophagitis (EoE). Esophageal eosinophilia means eosinophils are in the esophagus, >15 per high-power field in a biopsy. That could qualify as EoE when you go through the criteria of symptoms.   [12:19] We call it esophageal eosinophilia while we rule out everything else that could cause that cell to get recruited into the esophagus. It could be an allergic reaction to a medication, larger eosinophilic disorders, or parasitic infections. Esophageal eosinophilia means you had that initial biopsy that puts you at risk for EoE.   [13:06] You have to go down the diagnostic steps: Do I have symptoms? Do I have anything else that explains it? If you have nothing else that explains the eosinophils, and you have esophageal dysfunction, then you can call it EoE.   [13:33] Dr. Peterson, speaking personally, believes that educating doctors to ask patients about EoE symptoms would be useful in diagnosing EoE. People cope. You don't want to focus on your symptoms because you want to be able to focus on your life. If symptoms aren't brought to a doctor's attention, a diagnosis can get missed.   [16:47] Dr. Peterson discusses risks for EoE in families where allergies are present. Dr. Peterson is involved currently in another familial study to find more information about the risk of EoE where there are allergies in a family. In the preliminary data, it looks like there is a link with asthma. Asthma and EoE in a family seem to track together.   [17:31] The risk of EoE seems to be higher with additional allergies within a family. Dr. Peterson says they are cleaning up the data to get a better answer. It appears that allergies in general go along with some of the genes that have been identified in EoE. Watch for Dr. Peterson's papers going forward!   [19:05] They looked at around 300 eosinophilic gastroenteritis (EGE) patients and about 170 eosinophilic colitis (EoC) patients. If you have a proband with EoE, is there a higher family risk of having EGE or EoC? It looks like EoE puts you at higher risk of these other conditions. But with such low numbers in the study, the jury is still out.   [20:37] They looked at EGE codes because there is a subset of patients who have eosinophilic disease in their stomach and small bowel who don't have EoE. They found that in patients who have eosinophilic disease in the stomach or the small bowel, EoE is still commonly seen throughout families. EoE seems to be a common theme.   [21:54] Down the road, Dr. Peterson hopes to be able to identify enough families that they might be able to start looking at genes that might put people at risk for more extensive disease.   [23:07] Dr. Peterson discusses the difficulty in diagnosing eosinophilic colitis, inflammatory bowel disorder, and other disorders. Having eosinophils does not categorize you as an EGID patient. There are other disorders where eosinophils are present. We need a better understanding of eosinophilic colitis.   [25:21] Eosinophilic asthma and eosinophilic fasciitis are disorders that Dr. Peterson has not studied but are in the Institutional Review Board approved documentation for future study.   [26:18] Dr. Peterson addresses whether your degree of risk for an EGID increases if you have an immediate family member with an EGID, vs. a second cousin with an EGID. She would say yes, based on the hazard ratios in the data and knowing that eosinophilic disorders are complex and twin studies show an environmental influence.   [27:28] Dr. Peterson asks patients about their family history, especially when they have other symptoms besides EoE. It makes her more aware of what to test.   [29:10] A paper Dr. Peterson is about to submit studied family members who weren't affected, who were siblings of probands. Their mucosa wasn't entirely normal. They may be pre-diagnostic. These are patients who need to be followed. There may be things that set people up for the development of this disease, in the right environment.   [31:04] Something fascinating from the familial study is the challenge of diagnosing EGIDs. Fifty percent of the people they brought in hadn't had an endoscopy. We need to be proactive in identifying diseases in patients. In the study, there are a lot of general GI symptoms coded that Dr. Peterson wonders if they may be missed EGIDs.   [32:34] The NIH gave Dr. Peterson's team funding and they were able to do linkage analysis on several de-identified families that were at high risk for EGIDs. It looks like multiple genes have the potential to be involved. Personalizing medicine would be applicable if there were just one specific gene involved.   [33:23] Down the road, we may find some genes that portend higher risk and other genes that portend risk where we can do preventative environmental care. We can develop risk scores to identify risks and point to interventions.   [34:10] Mary Jo thanks Dr. Peterson for joining us today to share her expertise and help us learn and understand.   [34:36] Future research needs to be done where we are able to recruit patients and do more work looking at genetic linkage and get to the point where we can diagnose and identify non-EoE EGIDs well enough to explore them more, including eosinophilic colitis. Defining those diseases is necessary and needed.   [35:16] A lot of what Dr. Peterson is trying to do is to look further into combined diseases and hypereosinophilic states to determine if there is some gene within families that may help her to develop other therapies not focusing only on the GI tract but on a global approach to health for these patients.   [35:48] There is current research being done to find less invasive ways of identifying disease, such as imaging, so people don't have to undergo endoscopy. That research is being done on the commercial side.   [36:44] Dr. Peterson has been looking at food-specific antibodies. Also, research by other doctors is being done to identify other markers of the foods that often trigger the disease. There has been some interesting preliminary data. This can help patients to eliminate fewer foods.   [37:27] Dr. Peterson has been looking at less invasive ways to identify non-EoE EGIDs in ways that can avoid biopsy.   [38:04] What's being done to study Barrett's esophagus? Dr. Peterson speaks of past and planned research, using the Utah population database. They looked at the risk for Barrett's esophagus in patients with EoE and it was eight times higher than the normal population. Dr. Peterson correlates risks with reflux for Barrett's and EoE.   [39:26] There are still questions about which comes first, EoE, Barret's esophagus, or reflux. She also talks about the relationship between achalasia, allergic diseases, and EoE.   [41:05] To learn more about Dr. Peterson's research, please see the links in the show notes. To learn more about eosinophilic gastrointestinal disorders, please visit apfed.org/egids.   [41:29] To find a specialist, visit apfed.org/specialists. To connect with others impacted by eosinophilic diseases, please join APFED's online community on the Inspire Network at apfed.org/connections.   [41:48] Ryan and Mary Jo thank Dr. Kathryn Peterson again for joining them. Mary Jo thanks APFED's education partners, linked below, for supporting this episode.   Mentioned in This Episode: Kathryn A. Peterson, M.D. Pubmed.ncbi.nlm.nih.gov/36148824/ (to release February 2024) Pubmed.ncbi.nlm.nih.gov/33221551/ (published November 2020) University of Utah Health American Partnership for Eosinophilic Disorders (APFED) APFED on YouTube, Twitter, Facebook, Pinterest, Instagram Real Talk: Eosinophilic Diseases Podcast   Education Partners: This episode of APFED's podcast is brought to you thanks to the support of AstraZeneca, Bristol Myers Squibb, Sanofi, and Regeneron.   Tweetables:   “When we study familial risk, we're looking at the risk of the disease in a patient when a family member is affected, compared to the general population.” — Dr. Kathryn Peterson   “I think allergies, in general, kind of go along with some of the genes that have been identified in EoE.” — Dr. Kathryn Peterson   “Fifty percent of the people we brought in [to this familial risk study] hadn't had an endoscopy. We need to be proactive in identifying diseases in patients.” — Dr. Kathryn Peterson   About Dr. Kathryn Peterson Kathryn Peterson, MD is a Professor of Gastroenterology at the University of Utah Health. She is certified by the American Board of Internal Medicine.   Dr. Peterson specializes in diagnosing and treating diseases of the digestive system including eosinophilic esophagitis, Barrett's esophagus, and inflammatory bowel disease. She completed her medical degree at the University of Texas Southwestern, followed by residency and a fellowship at the University of Utah and a master's program in Epidemiology at Harvard University.   Bio: Healthcare.utah.edu/find-a-doctor/kathryn-peterson    .  

Discusses considerations for using artificial intelligence in Institutional Review Board operations. Our guest is Myra Luna-Lucero, EdD, the Research Compliance Director at Columbia University's Teachers College. She spearheaded the College's “Ethics & Safety Amid Uncertainty” initiative and co-chaired the Research Compliance & Safety Committee. She has also recently launched the “Research Writing & Ethics” internship program and oversaw an extensive transformation of the College's IRB website. She regularly offers seminars and workshops on research compliance and IRB leadership. A researcher and teacher herself, Dr. Luna-Lucero has studied and published on student motivation in STEM fields, barriers to accessing education for students in rural communities, and community activism.  Additional resources: CITI Program's Essentials of Responsible AI course: https://about.citiprogram.org/course/essentials-of-responsible-ai/ CITI Program's Technology, Ethics, and Regulations course: https://about.citiprogram.org/course/technology-ethics-and-regulations/ 

Welcome to the Lean to the Left podcast, where we explore progressive politics and the important social issues of our time.We're living in a time today when we might say that ethical behavior, particularly in politics, seems to be sorely lacking. We're looking at that as well as cultural processes of inequality that too often go undiscussed. Our guest is Dr. Amanda Udis-Kessler, a sociologist, antiracism trainer, writer, lay preacher, songwriter, and progressive sacred music composer. Her book Abundant Lives: A Progressive Christian Ethic of Flourishing will be published by Pilgrim Press in May 2024, and her book Cultural Processes of Inequality: A Sociological Perspective, will be published by Anthem Press in 2025. Her writing website is https://amandaudiskessler.com and her free-use sacred music website is https://queersacredmusic.com. Whether writing books, music, progressive liturgical materials, or antiracism training exercises, Amanda's goal is the same: to contribute to making a world in which there is a lot more joy and a lot less pain. She is Director of Assessment and Program Review and chair of the Institutional Review Board at Colorado College in Colorado Springs, Colorado. Here are questions we discussed with Amanda:Tell me about your approach to ethics and how it is connected to a left-leaning political perspective.How did you come to develop this approach to ethics and why do you think it's helpful?Tell me about how you see cultural processes of inequality working in the US.What are some of the important cultural processes of inequality? How are they similar or different across different forms of inequality?How does your way of thinking about inequality help progressives and left-leaning people work against inequality?Talk a little about the antiracism training you do. Why did you start doing it and what do you hope to accomplish with it?You wrote in a blog, “We all struggle to do what is good, especially when doing so is difficult and even more so when we live in a society that rewards hatred, cruelty, greed and power-mongering over love, kindness, generosity and service.” Has that society worsened in recent years when it comes to hatred, cruelty, greed and power-mongering?Do you believe that the ethics of politics has changed in recent years, and if so, why?You identify as a queer feminist. How do those identities inform your creative and intellectual projects?You consider yourself a composer of left-leaning worship music. What do you mean by that?How do your different identities and projects hang together? What's the relationship between developing a progressive ethic of flourishing, writing social justice worship music, offering antiracism trainings, and writing on the sociology of inequality?How can we make good choices regularly?This show is part of the Spreaker Prime Network, if you are interested in advertising on this podcast, contact us at https://www.spreaker.com/show/4719048/advertisement

Welcome to the Lean to the Left podcast, where we explore progressive politics and the important social issues of our time.We're living in a time today when we might say that ethical behavior, particularly in politics, seems to be sorely lacking. We're looking at that as well as cultural processes of inequality that too often go undiscussed. Our guest is Dr. Amanda Udis-Kessler, a sociologist, antiracism trainer, writer, lay preacher, songwriter, and progressive sacred music composer. Her book Abundant Lives: A Progressive Christian Ethic of Flourishing will be published by Pilgrim Press in May 2024, and her book Cultural Processes of Inequality: A Sociological Perspective, will be published by Anthem Press in 2025. Her writing website is https://amandaudiskessler.com and her free-use sacred music website is https://queersacredmusic.com. Whether writing books, music, progressive liturgical materials, or antiracism training exercises, Amanda's goal is the same: to contribute to making a world in which there is a lot more joy and a lot less pain. She is Director of Assessment and Program Review and chair of the Institutional Review Board at Colorado College in Colorado Springs, Colorado. Here are questions we discussed with Amanda:Tell me about your approach to ethics and how it is connected to a left-leaning political perspective.How did you come to develop this approach to ethics and why do you think it's helpful?Tell me about how you see cultural processes of inequality working in the US.What are some of the important cultural processes of inequality? How are they similar or different across different forms of inequality?How does your way of thinking about inequality help progressives and left-leaning people work against inequality?Talk a little about the antiracism training you do. Why did you start doing it and what do you hope to accomplish with it?You wrote in a blog, “We all struggle to do what is good, especially when doing so is difficult and even more so when we live in a society that rewards hatred, cruelty, greed and power-mongering over love, kindness, generosity and service.” Has that society worsened in recent years when it comes to hatred, cruelty, greed and power-mongering?Do you believe that the ethics of politics has changed in recent years, and if so, why?You identify as a queer feminist. How do those identities inform your creative and intellectual projects?You consider yourself a composer of left-leaning worship music. What do you mean by that?How do your different identities and projects hang together? What's the relationship between developing a progressive ethic of flourishing, writing social justice worship music, offering antiracism trainings, and writing on the sociology of inequality?How can we make good choices regularly?Become a supporter of this podcast: https://www.spreaker.com/podcast/the-lean-to-the-left-podcast--4719048/support.

Dr. Chris D'Adamo is an epidemiologist with expertise in the synergistic effects of healthy lifestyles, environmental exposures, and genetics on human health and wellness. He received his PhD in epidemiology, is the Director of the Center for Integrative Medicine at the University of Maryland School of Medicine, and is on the Scientific Advisory Board at Designs for Health.    Together we explore key differences in clinical trials in the pharma and natural product spaces, the benefits of third-party testing, and the many challenges of getting natural product studies approved.  Dr. Chris highlights his preferred supplements and lifestyle practices, offers advice to help practitioners guide their patients in supplement usage, and details the underrated, research-identified supplements that should be implemented in more diets for optimal health.  I'm your host, Evelyne Lambrecht, thank you for designing a well world with us. Key Takeaways: [1:20] The current state and challenges of natural products research. [3:00] Common hurdles to getting studies approved by the Institutional Review Board. [4:36] The impact of the Dietary Health and Supplementation Act (DSHEA) on identifying supplements as regulated food, not drugs. [5:15] Key differences between clinical trials in pharma and the natural product space. [6:55] Funding studies and the standard cost of IND trials. [8:26] Tactics for more effectively evaluating the findings of clinical trials. [11:00] Accounting for the genetic and dietary factors that affect the whole health of patients in research. [13:07] Chris shares advice for practitioner considerations when choosing a dietary supplement. [14:36] Resources for practitioners to help patients make informed decisions about supplement usage. [16:32] Top underrated supplements based on research that has demonstrated effectiveness. [21:44] Major nutrient deficiencies that are commonly identified in the research include Vitamin D and magnesium. [23:17] Reasons that doctors and insurance have stopped covering Vitamin D testing and treatments. [25:18] Research-backed facts addressing the dangers and benefits of protein intake in humans and animals. [30:13] Chris highlights his personal favorite supplements, his research on collagen, and his favorite health practices. [35:48] The importance of nasal breathing and other practices Chris has changed his mind about. Episode Resources: Chris D'Adamo   DSHEA Clinical Trial Registration Examine Mytavin The NIH Glucosamine/Chondroitin Arthritis Intervention Trial (GAIT) Design for Health Resources: Designs for Health Blog: Effects of Creatine on Brain Health and Function Blog: L-Carnitine for Energy Production and Beyond Blog: Creatine – Benefits Beyond Exercise Blog: Applications of the Antioxidant, Astaxanthin Blog: Research Review: Glucosamine and Chondroitin in Osteoarthritis Visit the Designs for Health Research and Education Library which houses medical journals, protocols, webinars, and our blog.

Dr. Kevin Voss, Director of the Center for Bioethics at CUW, joins Tiffany and Steph to talk about the field of bioethics and how our Lutheran theology helps us navigate the nuanced world of reproductive technology. Bio: Kevin Voss is a Professor of Philosophy and Director of the Center for Bioethics at Concordia University Wisconsin (CUW). He has been at CUW since 2003 and teaches philosophy, bioethics, and ethics courses. Dr. Voss has a PhD in Health Care Ethics from Saint Louis University, is an ordained Lutheran minister (Concordia Seminary St. Louis 1999), is a Fellow of Christian Apologetics, and is a licensed veterinarian, having practiced for 14 years in Bonduel, Wisconsin. He has authored peer-reviewed articles and written several articles for the Lutheran Witness. Rev. Voss has given numerous presentations about bioethics issues at national conferences. Dr. Voss is a member of the Sanctity of Human Life Committee of the Lutheran Church–Missouri Synod, the American Veterinary Medical Association, the American Society for Bioethics and Humanities, the American Association for Laboratory Animal Science, and the Evangelical Philosophical Society. He is Chair of Concordia University's Institutional Review Board. Learn about LCMS Life Ministry at lcms.org/life, and email us at friendsforlife@lcms.org. Not all the views expressed are necessarily those of the LCMS; please discuss any questions with your pastor.

Join Patti as she engages in a thought-provoking conversation with the brilliant Stanley K. Ridgley. Stanley, a Professor of Business at Drexel University, unveils the shocking attack on the Enlightenment University and the brainwashing process happening on college campuses. In his newly published book, "Brutal Minds," Stanley exposes the decline of higher education and offers powerful solutions to counter this alarming trend. Prepare to have your beliefs challenged and your eyes opened to the truth behind the scenes. This is an episode that will leave you questioning everything. Here's a breakdown of what to expect in this episode: • The Influence of Bureaucracy and Ideological Indoctrination in Higher Education • Criticizing Social Emotional Learning, Critical Race Theory, and Marxist Ideology in Schools • Unveiling the Role of Education Schools and Bureaucratic Mechanisms in Promoting Ideological Agendas • Protecting Academic Freedom • Exposing Radical Ideologies and Offering Strategies for Combatting Indoctrination in Higher Education • And so much more! About Stanley K. Ridgley: STANLEY K. RIDGLEY, PH.D. is a Clinical Full Professor of Management at Drexel University's LeBow College of Business. Dr. Ridgley has also studied at Moscow State University and the Institut de Gestion Sociale in Paris. He is a former Military Intelligence Officer who served in West Berlin and near the Czech-German border, where he received the George S. Patton Award for Leadership from the 7th Army NCO Academy. In addition to his teaching, Dr. Ridgley lectures widely in the United States and internationally. He is Drexel's faculty sponsor for Turning Point USA, serves on Drexel's Faculty Senate, and Drexel University's Institutional Review Board. He is a frequent contributor to national media, including Newsmax and American Greatness, and is also the highly praised faculty instructor for the course “Strategic Thinking” in the DVD series TheGreatCourses.com. He lives and works in the Philadelphia metro area. You can find Stanley K. Ridgley on . . . Website: brutalminds.com LinkedIn: https://www.linkedin.com/in/stanleyri... ~ Connect with Patti Katter! Website: https://pattikatter.com/ Instagram: https://www.instagram.com/PattiKatter/ Facebook: https://www.facebook.com/pkatter TikTok: https://www.tiktok.com/@pattikatter --- Send in a voice message: https://podcasters.spotify.com/pod/show/wakeupwithpattikatter/message Support this podcast: https://podcasters.spotify.com/pod/show/wakeupwithpattikatter/support

Robert DT on twitter: @DeeperThrill Doctorate on biomedical engineering with a focus on AI Entrepreneur building biomedical systems with AI specifically; medical imaging The conversation centers on the role of artificial intelligence (AI) in medical imaging, with an emphasis on computer vision and the utilization of existing imaging algorithms. Transformers, a type of deep learning model, are discussed for their unique self-attention mechanism and applications in natural language processing and computer vision. The talk pivots to data cleaning, specifically anonymization and safeguarding personal identifiers in the context of healthcare. Questions arise about data storage in healthcare facilities and the process of transferring it to the cloud. The conversation broadens to encompass AI's predictive capabilities and inherent risks, including the possibility of AI predicting third-order effects of its own interventions and concerns about excessive trust in AI predictions. The potential of AI in genetic engineering surfaces, particularly regarding CRISPR technology and nanobots. The conversation explores the benefits and risks of such advancements, including the revival of extinct plants and emergence of new diseases. Finally, the conversation shifts to societal implications of AI, including job displacement, the emergence of an attention economy, and the prospects of decentralized AI. The importance of understanding the limits of AI is underscored.   Show notes We need to examine what's currently happening in the field of AI, particularly in relation to medical imaging. This involves an exploration of computer vision technologies and how pre-existing imaging algorithms are being applied. We should discuss the concept of a "transformer" in the context of artificial intelligence. A critical part of working with AI is data cleaning. This includes the process of anonymization, ensuring that we only use the person's image and not any identifiable data like their name. We must also consider the storage of this data, which is typically housed on hospital servers. Additionally, there's the question of how this data is transferred to a cloud system for further processing. Let's explore the issue of gatekeeping in the field of AI. This might involve discussing the role of clinical trials and the Institutional Review Board in ensuring ethical standards. The engineering aspect of gatekeeping also requires attention, particularly when dealing with 3D data sets for imaging. We should highlight two major changes currently happening in the field of AI. Swin Transformers represent a significant development, as they are built off the concept of transformers in AI. Let's delve into the world of language modeling and chatbots. We must also consider the potential downsides of these AI technologies. The transhumanism angle presents an interesting point of discussion, particularly in relation to the next generation of technology. For example, the development of the mRNA vaccine was a major leap forward in response to global health crises. There's also the concept of generative mRNA vaccines, which use AI to generate potential cures. However, these AI technologies also come with risks. They could inadvertently create a disease, or develop a cure that isn't effective. The ease with which technology can be used in this field means that virtually anyone can make implants, leading to a new set of challenges. We should also discuss the emerging role of AI in lab-based work, such as managing petri dishes. The application of Hegelian principles to AI provides an interesting philosophical perspective. Looking ahead, we might consider what a lab kit might look like in ten years. The idea of the first version of something, and its relationship to anti-authoritarianism, is another interesting topic to explore. We have to acknowledge that AI, despite its potential, will not prevent all risks. AI can be used as a predictive tool for triaging, helping to determine whether an intervention will benefit a person. The use of CRISPR technology is another relevant point of discussion, especially considering its potential downsides, its application in nanobot technology, its use in regrowing extinct plants, the potential for new diseases arising from its use, and the systematics of finding new plant species in places like the Amazon. Let's also consider the case of the dodo and the role of technology in its extinction. With a small sample size, AI can predict certain outcomes, a feature that can be beneficial in various fields. Most plant species are discovered rather than created, and AI can potentially help in predicting where these new species might be found. The question arises: is AI better at predicting the future? It can certainly help us see larger scale patterns that we aren't aware of. However, the act of predicting the future can create its own issues, akin to the Oracle of Delphi dilemma. For instance, can AI predict the third-order effects of its own intervention? By revealing patterns, AI becomes a more effective tool. The more layers of patterns it can show us, the better. AI and Medical Imaging: AI is increasingly being used in medical imaging, particularly through deep learning techniques. These have applications in MRI, CT, and PET scans, enhancing image reconstruction, quality, and efficiency. While impressive progress has been made, the technology still needs further development before it can be widely applied in clinical settings Transformers: Introduced in 2017, transformers are a type of deep learning model used primarily in natural language processing and computer vision. They're distinguished by their use of self-attention, enabling them to process the entire input data all at once, rather than sequentially as in Recurrent Neural Networks (RNNs). This allows for more parallelization and thus reduces training times. Transformers have become the model of choice for many NLP problems, replacing RNN models such as long short-term memory (LSTM)

Why You Should Listen:  In this episode, you will learn about unraveling Bartonella. About My Guest: My guest for this episode is Dr. B. Robert Mozayeni.  B. Robert Mozayeni, MD is an expert in Translational Medicine, the science and art of advancing medical science safely and efficiently.  He is the Chief Medical Officer of Galaxy Diagnostics, LLC.  He is a co-founder of the Foundation for the Study of Inflammatory Diseases.  He serves as an advisor to pharmaceutical and nutraceutical companies and serves on an Institutional Review Board specializing in nutraceutical products for pain management.  He is the immediate past President of ILADS, the International Lyme and Associated Diseases Society where his goal was to advance the science of translational medicine.  In late 2019, Dr. Mozayeni launched T Lab Inc., a research and clinical laboratory engaged in research using advanced microscopy to understand better the pathogenesis of disease in inflammatory conditions associated with persistent infections.  He has research and clinical expertise with regard to autoimmune diseases and the effects of chronic infection and inflammation on vascular physiology and neurovascular conditions seen commonly with autoimmune and neurovascular diseases.  With a strong foundation in the basic sciences and evidence-based medicine, he analyzes complex medical cases using a combination of basic scientific principles and clinical experience along with the balance of the evidence base.  Dr. Mozayeni has published numerous papers on immunology and cerebrovascular blood flow hemodynamics.  He has been actively researching and publishing his work on chronic rheumatic diseases and their relationship to persistent human Bartonella spp. infection.  Of note, chronic persistent Bartonella spp. infections are strongly associated with neurovascular diseases.  Thus, Dr. Mozayeni is uniquely qualified in the combined areas of chronic persistent endovascular infections and related rheumatological and neurovascular diseases.  He has also published papers providing new insights as to a potential infectious  (Bartonella spp.) cause of osteoarthritis and also, a case of arthritis associated with hypermobility that was likely caused by Bartonella spp. Key Takeaways: What advances have been observed in recent years in the realm of Bartonella? What are common symptoms of Bartonella? How is Bartonella transmitted? Might Bartonella lead to autoimmunity? Can Bartonella be a trigger for PANS? Might Bartonella be a contributor to osteoarthritis? Is there a connection between Bartonella and hypermobility or EDS? Does Bartonella contribute to MS? What is the connection between Bartonella and SIBO? Can Bartonella act as a trigger for MCAS? Is Bartonella activation observed in those with COVID? What is the state of the art in Bartonella testing? What is Babesia odocoilei? What agents are most helpful in the treatment of Bartonella? Is there a place for herbs and other natural interventions in Bartonella treatment? Should pets be considered as a potential source of exposure to Bartonella? Connect With My Guest: http://TMGMD.com Related Resources: Article: Unraveling the Mystery of Bartonellosis Interview Date: May 24, 2023 Transcript: To review a transcript of this show, visit https://BetterHealthGuy.com/Episode185. Additional Information: To learn more, visit https://BetterHealthGuy.com. Disclaimer:  The content of this show is for informational purposes only and is not intended to diagnose, treat, or cure any illness or medical condition. Nothing in today's discussion is meant to serve as medical advice or as information to facilitate self-treatment. As always, please discuss any potential health-related decisions with your own personal medical authority. 

On this special episode of Inside the Firm, we are joined by Stanley K. Ridgley is a clinical full professor of management at Drexel University's LeBow College of Business. Dr. Ridgley has also studied at Moscow State University and the Institut de Gestion Sociale in Paris. He is a former Military Intelligence Officer who served in West Berlin and near the Czech-German border, where he received the George S. Patton Award for Leadership from the 7th Army NCO Academy. In addition to his teaching, Dr. Ridgley lectures widely in the United States and internationally. He is Drexel's faculty sponsor for Turning Point USA, serves on Drexel's Faculty Senate, and in Drexel University's Institutional Review Board. He is a frequent contributor to national media including Newsmax and American Greatness and is also the highly praised faculty instructor for the course, “Strategic Thinking” in the DVD series TheGreatCourses.com.

GUEST OVERVIEW: Stanley Ridgley (PHILADELPHIA, PENNSYLVANIA) is Clinical Full Professor of Management at Drexel University's LeBow College of Business. Dr. Ridgley has also studied at Moscow State University and the Institut de Gestion Sociale in Paris. He holds a Ph.D. in political science from Duke University, an International MBA from Temple University, and undergraduate degree from the University of North Carolina. He is a former Military Intelligence Officer who served in West Berlin and near the Czech-German border, where he received the George S. Patton Award for Leadership from the 7th Army NCO Academy. He is faculty sponsor for Turning Point USA, serves on Drexel's Faculty Senate, and on Drexel University's Institutional Review Board. Dr. Ridgley is a frequent lecturer and contributor to national media including NEWSMAX, American Greatness, Academic Questions, and is also the highly praised faculty instructor for the course “Strategic Thinking” in the DVD series TheGreatCourses.com. BrutalMinds.com

YouTube's new monetization process for Shorts will take effect in February, Microsoft Teams is introducing a new Premium edition, ChatGPT is being used by cybercriminals to create malware and fake girl bots, and a controversial non-consensual AI mental health experiment has sparked outrage. Stay tuned for the latest updates in the tech industry!00:00 - Intro01:45 - YouTube's New Shorts Monetization Process Will Come Into Effect in February10:42 - Some Microsoft Teams features will move to new Premium edition18:44 - Armed With ChatGPT, Cybercriminals Build Malware And Plot Fake Girl Bots24:34 - Controversy erupts over non-consensual AI mental health experimentSummary: Microsoft plans to move some features of its Microsoft Teams software to its more costly Premium edition in February. The features include live translated captions, custom Together Mode scenes, and virtual appointment options, which will only be available to users who purchase the Premium edition. The standard version of Teams will still have access to the features for 30 days after the launch of Premium. Microsoft Teams Premium is expected to cost $10 per user per month, and include AI-powered smart features such as live translations and advanced meeting protections.Cybercriminals have started using OpenAI's chatbot ChatGPT to build hacking tools, according to cybersecurity researchers. Scammers are also testing the chatbot's ability to build other chatbots designed to impersonate young females to ensnare targets. Underground criminal forums have caught on to the potential of ChatGPT, with one hacker sharing code written by the chatbot that stole files of interest, compressed them and sent them across the web. Another user shared Python code that could encrypt files, claiming OpenAI's app helped them build it.YouTube's new monetization process for Shorts, which allows creators to earn money from ads displayed between videos in the Shorts feed, will go into effect on February 1st. This new revenue sharing model replaces the YouTube Shorts Fund. Creators with over 1,000 subscribers and 10 million Shorts views over the preceding 90 days will be eligible to apply for a cut of ad revenue. YouTube expects this new process to be more sustainable and equitable, with payouts expected to be greater than creators currently receive from the Creator Fund.Koko, a nonprofit mental health platform, ran an experiment that provided AI-written mental health counseling to 4,000 people without obtaining their informed consent. The experiment used technology from OpenAI's GPT-3 large language model, which is behind the popular ChatGPT chatbot. People participating in the experiment rated the AI-crafted responses positively until they were informed that they were written by AI. Critics have raised concerns about the lack of informed consent and whether an Institutional Review Board approved the experiment. The company's co-founder has stated that the experiment is exempt from informed consent requirements as the results were not planned to be published.Our panel today>> Tarek>> Chris>> Henrike>> VincentEvery week our panel of technology enthusiasts meets to discuss the most important news from the fields of technology, innovation, and science. And you can join us live!https://techreview.axelspringer.comhttps://www.ideas-engineering.io/https://www.freetech.academy/https://www.upday.com/

Dr. Bryan Koenig is an assistant professor in the Department of Psychology and chair of SUU's Institutional Review Board. He holds degrees from St. John's University, College of William and Mary and New Mexico State University and has taught at SUU for the past five years. Dr. Koenig's teaching philosophy is centered on the belief that every student is unique, and structures his courses to provide students with opportunities to tailor their work to their interests. He actively engages his students by using a flipped teaching approach, including having class members replicate classic experiments. He continually looks to improve and excels at fostering solid relationships with his students. His wife, Crystal Koenig, is also an SUU faculty member, and their two children are their “tiny T-Birds.”Dr. Jayci Hacker has served as the Executive Director of Student Care & Advocacy and an Assistant Dean of Students at Southern Utah University since the summer of 2021. In this role, Jayci oversees the campus Care Team, Non-Clinical Case Management, the Office of Connection and Completion, and Graduate Assistants in the Psy.D. Program. Jayci provides QPR and Mental Health First Aid training for the campus. Prior to this role, Jayci served as the Honors Program Director and has been an SUU employee since January of 2012. Dr. Hacker recently completed her doctoral program at Arizona State University in Education and Leadership in December 2021. In the Spring of 2022, Jayci received the Gerald R. Sherratt Distinguished Service. 

Hey, Naturally Florida Listeners! As Extension agents, we need to report on our effort and impact over the year and we would LOVE to include some input from you! Please access our evaluation here: https://ufl.qualtrics.com/jfe/form/SV_bEf5YoxkFv87GIu This survey is a formal research study, approved by the University of Florida's Institutional Review Board. As a participant, you will need to complete an informed consent. You can skip any question you prefer not to answer and may stop participating at any time. Today's Episode: Mummies, Ghosts, and Goblins – oh my! This spooky season, we're chatting about Florida's bats! Thirteen species of bats call Florida home, yearround, and several more migrate in from the north or south at certain times of year. These amazing flying mammals, the only mammal with true flight, provide highly valuable pest management services for Floridians. So, while you may see some spooky vampire bats this month on TV or in the movies, remember - Florida bats eat insects … they don't suck blood! Learn more: (Webinar) Bats of Florida - https://youtu.be/gYhTjbBDqS8 (Taught by Shannon!) Read about high-quality bat houses in Florida - https://edis.ifas.ufl.edu/pdf/UW/UW29000.pdf Connect with the Florida Bat Conservancy to learn more: https://www.floridabats.org/backyard-bat-houses.html Living with Bats (FWC) - https://myfwc.com/conservation/you-conserve/wildlife/bats/ How You Can Help: Share what you learned with a friend! Bats are friends, not foe in Florida. Without them, we'd be dealing with so many more nighttime flying pest species. Consider leaving natural habitat for bats, like Spanish moss, dead palm fronds and their "boots" and, where possible, snags with cavities. Installing a bat house! Learn more about them, here: https://edis.ifas.ufl.edu/pdf/UW/UW29000.pdf and https://www.floridabats.org/backyard-bat-houses.html Sources for this Episode: https://edis.ifas.ufl.edu/publication/UW433 https://edis.ifas.ufl.edu/pdf/UW/UW28900.pdf https://myfwc.com/conservation/you-conserve/wildlife/bats/health/histoplasmosis/ https://www.whitenosesyndrome.org/static-page/where-is-wns-now https://www.usgs.gov/centers/nwhc/science/white-nose-syndrome If you enjoyed this episode, please consider sharing it with a friend who might enjoy learning about Florida's natural areas and the wild things that live here! --- Send in a voice message: https://anchor.fm/naturallyflorida/message

Dr. Judy Ho, Ph. D., ABPP, ABPdN is a triple board certified and licensed Clinical and Forensic Neuropsychologist, a tenured Associate Professor at Pepperdine University, and published author,  penning “Stop Self-Sabotage,” published by HarperCollins in August 2019; a book detailing a scientifically driven six-step program which has been translated into 7 additional languages around the world.  Her second book which she co-authored with Max Dubrow entitled "I'll Give it to Your Straight-ish: What Your Teen Wants You to Know," is published by Flashpoint and contains Dr. Judy's evidence-based tips to help parents raise healthy and resilient teenagers. Dr. Judy maintains a private practice in Manhattan Beach, CA where she specializes in comprehensive neuropsychological assessments and expert witness work.  She regularly appears as an expert psychologist on television, podcasts, radio, and contributes to other media including print and electronic periodicals. She is a co-host on the syndicate daytime television talk show “The Doctors,” co-host of CBS's Face the Truth, and host of The SuperCharged Life podcast which focuses on scientific, tangible tips for physical and mental wellness, and strategies for motivation and productivity, produced by Stage 29 Podcast Productions. Dr. Judy Ho is an avid researcher and is a two-time recipient of the National Institute of Mental Health Services Research Award. She hosts an active research program to improve mental health care for high-need populations and is the chair of the Institutional Review Board at Pepperdine University. Her treatment approaches integrate the scientific principles of Cognitive Behavioral Therapy, Acceptance and Commitment Therapy, and Dialectical Behavioral Therapy. She often speaks at national and local events including research, clinical, and corporate conferences and workshops for organizations and schools. Dr. Judy received her bachelor's degrees in Psychology and Business Administration from UC Berkeley, and her masters and doctorate from SDSU/UCSD Joint Doctoral Program in Clinical Psychology. She completed a National Institute of Mental Health sponsored fellowship at UCLA's Semel Institute. DR. JUDY HO Online: Twitter: https://twitter.com/drjudyho Instagram: https://www.instagram.com/drjudyho/ Facebook: https://www.facebook.com/doctorjudyho LinkedIn: https://www.linkedin.com/in/drjudyho/ Web: www.drjudyho.com  JONES.SHOW Online:    Join us in the Jones.Show Lounge on Facebook. Twitter (Randy): https://twitter.com/randallkjones  Instagram (Randy): https://www.instagram.com/randallkennethjones/ Facebook (Randy): https://www.facebook.com/mindzoo/ Web:  RandallKennethJones.com Follow Randy on Clubhouse Twitter (Susan): https://twitter.com/SiriouslySusan Instagram (Susan): https://www.instagram.com/siriouslysusan/ Facebook (Susan): https://www.facebook.com/siriouslysusan/ Web: SusanCBennett.com Follow Susan on Clubhouse LinkedIn (Kevin): https://www.linkedin.com/in/kevin-randall-jones/  Web: KevinRandallJones.com  www.Jones.Show

Cody Morris is the director of the graduate program in behavior analysis and the chair of the Institutional Review Board at Salve Regina. The overarching goal of his research and clinical focus is improving the practice of behavior analysis. To this end, Cody's research has two major concentrations. The first and primary concentration is improving assessment and treatment methodologies for severely challenging behavior in clinical settings. The second concentration is addressing organizational issues related to the delivery of behavior analysis. --- Support this podcast: https://anchor.fm/out-of-the-blank-podcast/support

Hey, Naturally Florida Listeners! As Extension agents, we need to report on our effort and impact over the year and we would LOVE to include some input from you! Please access our evaluation here: https://ufl.qualtrics.com/jfe/form/SV_bEf5YoxkFv87GIu This survey is a formal research study, approved by the University of Florida's Institutional Review Board. As a participant, you will need to complete an informed consent. You can skip any question you prefer not to answer and may stop participating at any time. Today's Episode: The state of Florida is famous for its sunshine, beaches, and summertime fun. However, as Floridians, we know that summer also means thunderstorms, and thunder doesn't happen without lightning. In this episode, we will explore the basic science of lightning and thunder, and how you can keep yourself safe this summer. We hope this brief introduction to thunderstorms in Florida will help you feel more informed and prepared for our summer rainy season. Learn more: Understanding Lightning: Thunderstorm Electrification - www.weather.gov/safety/lightning-science-electrification Severe Weather 101: Frequently Asked Questions About Lightning - www.nssl.noaa.gov/education/svrwx101/lightning/faq Understanding Lighting: Thunder - www.weather.gov/safety/lightning-science-thunder How You Can Help: Share what you learned with a friend! Remember these sayings: "NO Place Outside Is Safe When Thunderstorms Are In The Area!", "When Thunder Roars, Go Indoors!, and "Half An Hour Since Thunder Roars, Now It's Safe To Go Outdoors!" Educate yourself and others with these lightning safety tips and resources - www.weather.gov/safety/lightning Sources for this Episode: Understanding Lightning: Thunderstorm Electrification - www.weather.gov/safety/lightning-science-electrification Severe Weather 101: Frequently Asked Questions About Lightning - www.nssl.noaa.gov/education/svrwx101/lightning/faq Understanding Lighting: Thunder - www.weather.gov/safety/lightning-science-thunder Clouds – How Do They Form? - www.weather.gov/source/zhu/ZHU_Training_Page/clouds/cloud_development/clouds.htm Lecture Notes in Electrical Engineering 780, Chandima Gomes (Editor). “Lighting - Science, Engineering, and Economic Implications for Developing Countries”. Springer. If you enjoyed this episode, please consider sharing it with a friend who might enjoy learning about Florida's natural areas and the wild things that live here! Thunderstorm sound clips licensed from Bidgee, CC BY-SA 3.0 AU, via Wikimedia Commons --- Send in a voice message: https://anchor.fm/naturallyflorida/message

George R. Mastroianni served as a US Army Research Psychologist, where he worked in a variety of biomedical laboratories and other military research settings. His research experience included aviation human factors, the effects of laser exposure on human vision and performance, modeling and simulation of human performance, and operational testing of new Army equipment. Dr. Mastroianni worked as a Professor of Psychology at the US Air Force Academy in Colorado Springs, CO from 1997 until 2016, where he taught Biopsychology, Learning and Memory, Sensation and Perception, and Introduction to the Behavioral Sciences. He also served as Chair of the Institutional Review Board and as Chair of the Institutional Animal Care and Use Committee. Dr. Mastroianni currently teaches in the Master's in the Psychology of Leadership program in the World Campus at the Pennsylvania State University.Dr. Mastroianni has published widely and co-edited A Warrior's Guide to Psychology and Performance, created on the model of two WWII works produced for soldiers by psychologists. Dr. Mastroianni is interested in leadership and ethical behavior, and has commented extensively on the 2003 abuses at Abu Ghraib. His scholarly interests for the last several years have centered on the psychology of the Holocaust. His book, Of Mind and Murder: Toward a More Comprehensive Psychology of the Holocaust, was published by Oxford University Press September 7, 2018. His most recent works are Misremembering the Holocaust: The Liberation of Buchenwald and the Limits of Memory and Rumors of Injustice: The Cases of Ilse Koch and Rudolph Spanner.Dr. Mastroianni makes occasional contributions to his blog on the Times of Israel website. Recent posts have addressed inaccuracies in material on the US Holocaust Memorial Museum website, and  Havana Syndrome.You can follow Dr. Mastroianni and purchase his books at GeorgeMastroianni.com.***Follow the Greg Krino Show here...GregKrino.comYouTubeInstagramFacebookTwitterLinkedInIf you enjoyed the podcast, please leave a 5-star rating and friendly comment on your podcast app. It takes only a minute, and it really helps convince popular guests to join me.If you have comments or ideas for the show, please contact me at gregkrinoshow@gmail.com.

Why did Knockin' Doorz Down podcast host Jason LaChance want to talk with Adam Jablin? Adam Jablin is a highly sought-after performance and life coach, corporate consultant, and keynote speaker. Jason wanted to pick his brain on various areas of self-improvement and discuss such topics as imposture syndrome, self-sabotage, and being present in the moment.  Adam has helped thousands of people over the years experience joy in living even while under pressure or difficulty. His unique positive energy, compassion, and gift to relate to others have influenced people from all walks of life, including leaders in the fields of health, psychology, entertainment, sports, business, and politics as well as helping everyday folks fight fears, alcoholism and addictions to unleash their hidden Superman. His knowledge from helping to build, run, and sell a multimillion-dollar corporation is invaluable. Equally important are Adam's sobriety and his experiences as an enthusiastic advocate of recovery. (Clean & Sober since July 14th, 2006.) Adam is also the creator of the Hero Project – a high-level coaching program where you become the hero of your own life. Adam also sits on the Institutional Review Board at Hanley Center— one of the most successful and highly regarded addiction and recovery treatment programs in the United States. Adam lives in Delray Beach, Florida with his family. In his spare time, he enjoys fitness activities and is a former bodybuilding champion.  This is Adam Jablin in his own words, on the Knockin' Doorz Down podcast. For more on Adam Jablin https://adamjablin.com/  For 51FIFTY use the discount code KDD20 for 20% off! https://51fiftyltm.com/ For more information on Carlos Vieira's autobiography Knockin' Doorz Down, the Carlos Vieira Foundation, the Race 2B Drug-Free, Race to End the Stigma, and Race For Autism programs visit: https://www.carlosvieirafoundation.org/  Listen to and Subscribe to the podcast on all platforms for more amazing interviews at https://www.KDDPodcast.com © 2021 by KDD Media Company. All rights reserved. #MikeDiamond #onedayatatime #wedorecover

Who has access to data and what can be done with that data? Shannon Ellis, Ph.D., shares how she is training undergraduate students to be effective, inclusive and ethical data scientists. She discusses how data can be used, the limits of data science, and the barriers and biases that may shape data sets and potential conclusions. Series: "Data Science Channel" [Science] [Education] [Show ID: 37838]

Who has access to data and what can be done with that data? Shannon Ellis, Ph.D., shares how she is training undergraduate students to be effective, inclusive and ethical data scientists. She discusses how data can be used, the limits of data science, and the barriers and biases that may shape data sets and potential conclusions. Series: "Data Science Channel" [Science] [Education] [Show ID: 37838]

Who has access to data and what can be done with that data? Shannon Ellis, Ph.D., shares how she is training undergraduate students to be effective, inclusive and ethical data scientists. She discusses how data can be used, the limits of data science, and the barriers and biases that may shape data sets and potential conclusions. Series: "Data Science Channel" [Science] [Education] [Show ID: 37838]

Who has access to data and what can be done with that data? Shannon Ellis, Ph.D., shares how she is training undergraduate students to be effective, inclusive and ethical data scientists. She discusses how data can be used, the limits of data science, and the barriers and biases that may shape data sets and potential conclusions. Series: "Data Science Channel" [Science] [Education] [Show ID: 37838]

Who has access to data and what can be done with that data? Shannon Ellis, Ph.D., shares how she is training undergraduate students to be effective, inclusive and ethical data scientists. She discusses how data can be used, the limits of data science, and the barriers and biases that may shape data sets and potential conclusions. Series: "Data Science Channel" [Science] [Education] [Show ID: 37838]

Who has access to data and what can be done with that data? Shannon Ellis, Ph.D., shares how she is training undergraduate students to be effective, inclusive and ethical data scientists. She discusses how data can be used, the limits of data science, and the barriers and biases that may shape data sets and potential conclusions. Series: "Data Science Channel" [Science] [Education] [Show ID: 37838]

There's lots of research going on about video games.  Some of it involves product testing like VR games or the effectiveness of interfaces.  Some of it looks at the impact of gaming on players for things like violence, sexism, and addiction.  What ethical concerns come into play when doing research like this on live human beings like you and I? --------------------------- Ashley ML Guajardo is an associate professor of Entertainment Arts and Engineering at the University of Utah where she teaches game design and games user research. When she isn't researching Twitch streamers or Twitch streaming herself, she serves on the Institutional Review Board and is currently co-directing the #gamesUR Summit 2022- the largest conference for games user researchers. Ann Johnson has degrees in biology, chemistry, and public health, and her career is making sure people who volunteer to be in research studies are as safe and respected as possible.  She's  the Director of the University of Utah's IRB & Human Research Protection Program --------------------------- JOIN THE ETHICS AND VIDEO GAMES COMMUNITY: - Follow/like/share us on Facebook, Twitter, and YouTube  - Explore our website and check out our Video Games Ethics Resources Center: https://ethicsandvideogames.com - If you're game to lend us your financial support, we'd love to have it and can definitely use it!  You can do that here: SUPPORT OUR PODCAST! - Give us a review whereever you listen to podcasts - If you've got an idea or an ethical issue involving video games that you think would make for a good podcast, please let us know!  Contact us at ethicsandvideogames.com or email us at contact@ethicsandvideogames.com.  We'd love to hear from you! Hosted by Shlomo Sher, Ph.D. and Andy Ashcraft Production by Carmen Elena Mitchell Music and graphics by Daniel Sher

In this Legacy Interview, CEO Greta Chapman sits down with Inductee Loren Tschetter to discuss his life and Legacy in South Dakota.After attending medical school, and completing his residency, Dr. Loren Tschetter established his practice of internal medicine, hematology, and oncology in Sioux Falls South Dakota. In this practice, Loren was a pioneer, and instrumental in establishing a research clinical treatment program as a part of patients' treatment for their cancer. In order to do this, he focused on patient education, a strong and supportive staff, and helped establish the first Institutional Review Board. Dr. Tschetter is known for his empathy and care for his patients and has not only changed lives but has saved lives throughout South Dakota. Follow us for more stories of Dream Chasers at:Facebook: www.facebook.com/SDhalloffameInstagram: @sdhalloffameWebsite: www.sdexcellence.orgProduced by Vela Creative Co., recorded by South Dakota Public Broadcasting.

In this interview, I talk to Adam Jablin a life coach and recovery expert about the effect of the Covid pandemic on teens and how we as parents can help.Adam Jablin is the author of Lotsaholic: https://amzn.to/3H9rAo5 and you can find him at Contact Adam at: https://www.adamjablin.com/ and on Instagram @AdamJablinAdam has helped thousands of people over the years experience a joy for living even while under pressure or difficulty. His unique positive energy, compassion, and gift to relate to others has influenced people from all walks of life, including leaders in the fields of health, psychology, entertainment, sports, business, and politics as well as helping everyday folks fighting fears, alcoholism and addictions to unleash their hidden Superman.His knowledge from helping to build, run, and sell a multimillion-dollar corporation is invaluable. Equally important is Adam's sobriety and his experiences as an enthusiastic advocate of recovery. (Clean & Sober since July 14th, 2006.) Adam is also the creator of the Hero Project – a high level coaching program where you become the hero of your own life.Adam also sits on the Institutional Review Board at Hanley Center— one of the most successful and highly regarded addiction and recovery treatment programs in the Untied States.Adam lives in Delray Beach, Florida with his family. In his spare time, he enjoys fitness activities and is a former bodybuilding champion.

In this podcast, Nadine Rosenblum and Nurse Scientist Heather Watson meet to continue the discussion about the Institutional Review Board. They discuss types of IRB applications, stakeholders to include, training for study team participation and other requirements for submitting an application to the IRB. They wrap up the discussion by inviting people to contact the […]

In this podcast, Nadine Rosenblum and Nurse Scientist Heather Watson meet to talk about the Institutional Review Board. They discuss the types of projects that need IRB approval. They also discuss what role a Principal Investigator plays, as well as the co-Investigator and other study team roles. They wrap up the discussion by inviting people […]

Many people struggle when it comes to submitting to the IRB. Dr. Lacy shares the common mistakes people make, and gives advice to make submitting to the IRB, the Institutional Review Board, a smooth process. Follow along on Instagram: https://www.instagram.com/marvettelacy/ Join the discussion on Facebook: https://www.facebook.com/groups/qualitativedissertationsmadesimple  

Get 20% off @manscaped + Free Shipping with promo code ALPER at MANSCAPED.com #ad #manscapedpod Zach and I have an increasingly interesting conversation that starts off with the dangers of social media, more thoughts on stress, anxiety and our differing opinions and experiences throughout college so far. We then talk about psychological issues and how many experiences are no longer able to be tested because of Institutional Review Board's which ties into individualism and collectivism. The use of drugs to solve issues and our differing opinions on use leads to a great conversation about morals, which brings in the morality of politics and Artificial Intelligence stealing our jobs in America. As you can see, we talk about a whole bunch of shit with a lot more topics strapped in between. This is an episode you do not want to miss, enjoy :) Like, Share and Subscribe! Feel free to message us to discuss anything, we love the support! Follow and keep up with Zach down below: Zach's Socials: Instagram - zach.reggio Brandon's Socials: Instagram: @clout.alper Twitter: @brandonalper21 Snapchat: @brandonbball21 I love you guys. Stay safe everybody :)

With U.S. Treasury Secretary Jane Yellen saying that inflation would be “a good thing” for us, I ask Dr. Merrill Matthews, resident scholar with the Institute for Policy Innovation, about the situation. [See: Yellen Admits Inflation Is About To Surge But Says It Will Be ‘Plus For Society’s Point Of View’ https://dailycaller.com/2021/06/07/janet-yellen-treasury-department-joe-biden-inflation-interest-rates/ ] Also we discuss the disaster of Biden paying people not to work and how that is affecting economic growth as “Biden’s Backdoor Scheme for Effectively Raising the Minimum Wage,” was a recent column by Matthews. [See: https://www.ipi.org/ipi_issues/detail/bidens-backdoor-scheme-for-effectively-raising-the-minimum-wage ] Merrill Matthews, Ph.D., is a resident scholar with the Institute for Policy Innovation, a research-based, public policy “think tank.” He is a health policy expert and opinion contributor at The Hill. He also serves on the Texas Advisory Committee of the U.S. Commission on Civil Rights. Dr. Matthews is a past president of the Health Economics Roundtable for the National Association for Business Economics, the largest trade association of business economists. Dr. Matthews also served for 10 years as the medical ethicist for the University of Texas Southwestern Medical Center’s Institutional Review Board for Human Experimentation, co-author of On the Edge: America Faces the Entitlements Cliff, and has contributed chapters to several books, including Physician Assisted Suicide: Expanding the Debate and The 21st Century Health Care Leader and Stop Paying the Crooks (on Medicare fraud). He has been published in numerous journals and newspapers, including The Wall Street Journal, Investor’s Business Daily, Barron’s, USA Today, Forbes magazine and the Washington Times. He was an award-winning political analyst for the USA Radio Network and is a regular contributor to Pratt on Texas. Dr. Matthews received his Ph.D. in Humanities from the University of Texas at Dallas. https://www.ipi.org/authors/detail/merrill-matthews www.PrattonTexas.com

TeachAids is a social venture that grew out of Stanford and Dr. Piya Sorcar's doctoral work. "This effort grew into a collaborative consortium of world-class experts from disciplines including education, medicine, communications, technology, and design thinking. The Institutional Review Board-approved research and methodology has demonstrated statistically significant gains in learning and retention, and provided the highest learning effects and comfort rates of any tested educational approach.1 " Scott Anderson (Episode 45), Chief Clinical Officer (CCO) at SyncThink, former Director of Athletic Training/Sports Medicine at Stanford University and an advisor to TeachAids. Scott was instrumental in the creation of the TeachAids for Concussion product, CrashCourse. He talks about the amazing work that TeachAids is doing, including the incredible FREE CrashCourse products such as the Concussion Story Wall, Concussion Education - including in VR (virtual reality), Brain Fly-Through - including VR!

Why does the FDA have three systems in place to address and handle risk related to medical devices? Each system serves a different purpose, but are all three actually necessary?In this episode of the Global Medical Device Podcast, Jon Speer talks to Mike Drues from Vascular Sciences about FDA's three systems of risk for medical devices and the unique interdependencies and distinctions between them.Some highlights of this episode include:Three systems for medical device risk from FDA: product classification, significant vs. nonsignificant risk, software level of concern.The FDA's classification system handles risk by classifying medical devices as Class I, II, or III. The higher the class, the higher the risk. The lower the class, the lower the risk. Yet, risk is a broad subject and there are a ton of exceptions.Also, classification numbers/levels used by the FDA in the United States do not translate in a linear way to those in the European Union (EU) and elsewhere. There are similar systems but different rules that are philosophically different. The significant vs. nonsignificant risk system focuses on clinical trials for medical devices. All clinical evaluations of investigational devices, unless exempt, must have an approved investigational device exemption (IDE).The software level of concern is important because it determines the level of documentation required for software development. The default classification for any new medical device is Class III. If it's a new device, it's not well-established and the benefits and risks are relatively unknown.When it comes to labeling, say anything as long as you can prove and support it. When technology stays the same but the labeling claim changes, risk changes. The determination of significant or nonsignificant risk is not made by the FDA or Institutional Review Board (IRB), but the medical device company.The software level of concern consists of Class a, b, and c. Does the software have no possibility of causing injury or damage to health? Is non-serious injury possible? Or, is serious injury or death possible?Memorable quotes by Mike Drues:“Theoretically, the classification of your medical device depends on risk. In other words, the higher the class, the higher the risk. The lower the class, the lower the risk.”“The default classification for any new medical device is Class III, which basically means we set the bar at the highest possible level.”“Oftentimes in regulation, we do things not because they make sense, but because that's the way we've done them in the past.” “The determination of significant or nonsignificant risk is not up to the FDA. It's not even up to your IRB, or Institutional Review Board, it's up to the company.”Links:FDA - Classify Your Medical DeviceFDA - Significant Risk and Nonsignificant RiskFDA - Software Level of ConcernFDA - Product Code Classification DatabaseInvestigational Device Exemption (IDE)De Novo Classification ProcessCenter for Devices and Radiological Health (CDRH)Requests for Feedback and Meetings for Medical Device SubmissionsMike Drues on LinkedInGreenlight Guru Webinar - Advanced Strategies and Tactics for Using the De Novo PathwayGreenlight Guru Webinar - Understanding the Medical Device Classification SystemGreenlight Guru Podcast EP 37: Significant Risk vs. Nonsignificant Risk Devices - What's the Difference? Greenlight Guru AcademyThe Greenlight Guru True Quality Virtual SummitGreenlight Guru YouTube ChannelMedTech True Quality Stories PodcastGreenlight Guru

Dr Dale Bredesen sits down with Dr Daniel and Tana Amen to discuss the serious threat Alzheimer's disease still represents to the world’s population. Bredesen shares how difficult getting a simple trial approved by the Institutional Review Board can be and how some groundbreaking work is being overshadowed, thanks to corporate interest.

This week Matt Crespin is joined by Laurie Brenchley RDH, BS who works for the National Institute of Health in the NIDCR Oral Immunity and Inflammation Unit to talk about research and the work she does!    Episode Highlights Updates from ADHA Laurie’s Journey  Laurie’s Position at NIH Research Nurses Pandemic Impact Quotes   “As I was treating some of these patients, I noticed I was really interested in treating patients that had immunodeficiencies.”    “I saw this as my dream job and I still do.”   “I see them clinically and take research samples from those patients.”   “Annually our research protocol is reviewed by the Institutional Review Board.”    “For three years it was just me seeing all of the patients in the hospital.”   “Limiting the number of patients that come into the hospital has been the biggest change with the pandemic.”    “We at the NIH, but also citizens of the United States, are so lucky to have him.”    “You learn a lot by looking at the data collection, you are not out of the loop.”   “If you voice your desire, there are doors that can be opened for those who don’t want to only do clinical treatment.”  Links    $20 in 2020 Challenge! https://charity.gofundme.com/o/en/campaign/20in2020    Matt’s Email: MattC@ADHA.net  ADHA Annual Report: https://www.adha.org/annual-reports    The health and wellness of the dental hygiene community and the patients you serve is our top priority. We are closely monitoring developments surrounding COVID-19 and will continue to keep you informed. For more information from ADHA, visit https://www.adha.org/covid19.   Visit www.adha.org for membership processing, membership updates, renewals and conference registration! FAQ: https://www.adha2020.org/faq/    Email for COVID Questions/Input: rdhcovidinfo@adha.net    Resource Center: https://www.adha.org/covid19  American Dental Hygienists’ Association homepage:   https://www.adha.org/ ADHA Facebook Page:   https://www.facebook.com/youradha/ The Dental Podcast Network Channel One homepage: http://dentalpodcastnetworkchannelone.otcpn.libsynpro.com/   

Doctors Mike Flynn and Gene Shively discuss the clinical trial process of testing new drugs and medical devices with Dr. Laura Clark, Chair of the Institutional Review Board at the University of Louisville

Can you move from being Captain Denial becoming the hero of your own life? Our guest today knows that you can and can help you make the transformation through his Hero Project. Adam Jablin is a highly sought-after performance and life coach, corporate consultant, and keynote speaker who has helped thousands of people experience a joy for living even while under pressure or difficulty. His unique positive energy, compassion, and gift to relate to others has influenced people from all walks of life, including leaders in the fields of health, psychology, entertainment, sports, business, and politics as well as helping everyday folks fighting fears, alcoholism and addictions to unleash their hidden Superman.   In today's episode we talk about his 5 strategies (plus one added by Michael) for successfully closing out 2020 and preparing for 2021 and beyond, including the practice of meditation, journaling and more. ​ Adam helped build, run, and sell a multimillion-dollar corporation in the fashion world, but equally important to his story is Adam's sobriety and his experiences as an enthusiastic advocate of recovery. (Clean & Sober since July 14th, 2006.) Adam also sits on the Institutional Review Board at Hanley Center— one of the most successful and highly regarded addiction and recovery treatment programs in the Untied States.   Listen in! Learn More: https://www.adamjablin.com/ https://www.facebook.com/adam.jablin https://www.instagram.com/adamjablin/ https://www.linkedin.com/in/adam-jablin-9548646/  

In this new episode, the newly formed enterprise, Tribal Research Specialist (TRS), provides a brief introduction to our services and vision. As usually, the episode starts with a song. In this case, the song comes from a private reel-to-reel collection. The song was unmarked and unattributed to the artists. The TRS discusses the possible origin of the song and asks listeners to provide what they may know.  The episode continues with a discussion concerning issues surrounding the encroachment of Institutional Review Board protocol in Tribal community research. Further, the discussion focuses on Tribal Nations advancements and how this progress has required adaptations that have not always reflected Tribal values. This aligns with many other issues that can arise when Tribal people and our unique traditions and philosophies are subjugated by Federal and societal pressures.The second half of the episode revisits the same song while still maintaining the discussion surrounding ethnographic approached to Tribal Phenomenon used by Tribal researchers. The sharing of knowledge is discusses as straying from the spirit of generosity. This is not to ignore the fact that IRB's were and are intended to protect Tribal people from exploitation, yet how far do we have to go to emulate a process that does not align with the realities of Tribal life.Additionally, the TRC discussion veers into thoughts of 90's powwow music as an example of shifting ideologies and values related to sharing.   Have answers? Suggestions? Agree? Disagree? Join the conversation at one of our social media sites. Your input is valuable to advance our understanding.Hosts: Aaron Brien, Shandin PetePlease visit our sponsor for this episode! --->  https://wyld.gallery/PodCast Website: tribalresearchspecialist.buzzsprout.comApple Podcast: https://podcasts.apple.com/us/podcast/tribal-research-specialist-the-podcast/id1512551396Spotify: open.spotify.com/show/1H5Y1pWYI8N6SYZAaawwxbTwitter: @tribalresearchspecialistFacebook: www.facebook.com/TribalResearchSpecialistYouTube: www.youtube.com/channel/UCL9HR4B2ubGK_aaQKEt179QWebsite: www.tribalresearchspecialist.comSupport the show (https://www.patreon.com/TribalResearchSpecialist)

Dana Laake and her special guest Adam Jablin will discuss recovering from addiction. Adam Jablin is a highly sought-after life coach, corporate consultant, and keynote speaker. Adam has helped thousands of people experience a joy for living, even while under pressure or difficulty. His unique positive energy, compassion, and gift to relate to others has influenced people from all walks of life, including leaders in the fields of health, psychology, entertainment, sports, business and politics, as well as helping everyday folks fighting fears, alcoholism and addictions to unleash their hidden Superman. Adam is the creator of the Hero Project, a high-level coaching program where you become the hero of your own life. He also sits on the Institutional Review Board at Hanley Center, one of the most successful and highly regarded addiction and recovery treatment programs in the United States.

How great would it be to actually be able to GO TO the doctor’s office?   Remember when it was a thing for people to actually do that? To actually go to the doctor’s office   Did we really need to do that as often as we did?   Or at least as often as we should have?   According to our friends at MedicalEconomics.com, patients are ready for easier access to healthcare professionals. In the early days of COVID19, 71% of patients had considered telemedicine half had already gone through with a virtual appointment. Patient adoption at the beginning of 2020 was up 33% over the previous year and Venture capital fundingfor telemedicine companies surged in the first quarter of 2020 to $788 million. The market is expected to reach $185.6 billion by 2026.   Here’s a tough question: Does it actually help?   On this week’s InSecurity, Matt Stephenson has a chat with Pete Fronte, founder & CEO of Altura, a 20 year old company who has built a mechanism that connects medical clinical studies with the people who need to be studied. In the contemporary world of telehealth and everything-from-home, people need access more than ever. COVID is the new horror on the block. People still need access to studies on cancer, heart disease and every other healthcare issue that existed prior to 2020… check it out     About Pete Fronte     Pete Fronte is the founder and President/CEO of Altura. During the past 20 years Mr. Fronte has been a leader in engaging people for better health via health studies, health experience surveys and health programs. He has been a catalyst for developing innovative processes and technology to accelerate the study and adoption of new medical interventions (e.g. drugs, biologics, medical devices, wearables). Pete’s passion centers on expanding participation in health studies by engaging and enabling patients and health care providers (HCPs). He is a recognized leader in patient centered outreach including Patient Study Life Cycle™ management. Today he continues to lead the expansion of clinical research, evidence based medicine and real word studies into primary care and organized healthcare settings nationally. Mr. Fronte has spearheaded innovative technology such as Altura's Study Engagement Platform which HCP Studies mobile app which is available in 23countries. Pete’s experience includes collaborating with medical groups, integrated health systems, pharmacy and medical management companies, research centers, institutional review boards (IRBs) and study sponsors to design and implement innovative study awareness and patient centered projects that include HIPAA compliant utilization of various forms of electronic health data as well as mobile applications and web portals. Mr. Fronte is currently a member of the Institutional Review Board at St. Joseph Health in Orange County California and is active in various healthcare and clinical research trade associations. He is a national speaker and writer on subjects such as; innovative patient and HCP engagement programs for clinical studies, and health program, site based clinical research operations and the integration of clinical research within primary care and organized healthcare systems.     About Matt Stephenson     Insecurity Podcast host Matt Stephenson (@packmatt73) leads the Broadcast Media team at BlackBerry, which puts him in front of crowds, cameras, and microphones all over the world. He is the regular host of the InSecurity podcast and video series at events around the globe.   I have spent the last 10 years in the world of Data Protection and Cybersecurity. Since 2016, I have been with Cylance (now BlackBerry) extolling the virtues of Artificial Intelligence and Machine Learning and how, when applied to network security, can wrong-foot the bad guys. Prior to the COVID shutdown, I was on the road over 100 days a year doing live malware demonstrations for audiences from San Diego to DC to London to Abu Dhabi to Singapore to Sydney. One of the funniest things I've ever been a part of was blowing up a live instance of NotPetya 6 hours after the news broke... in Washington DC... directly across the street from FBI HQ... as soon as we activated it a parade of police cars with sirens blaring roared past the building we were in. I'm pretty they weren't there for us, but you never know...   Every week on the InSecurity Podcast, I get to interview interesting people doing interesting things all over the world of cybersecurity and the extended world of hacking. Sometimes, that means hacking elections or the coffee supply chain... other times that means social manipulation or the sovereign wealth fund of a national economy.   InSecurity is about talking with the people who build, manage or wreck the systems that we have put in place to make the world go round...   Can’t get enough of Insecurity? You can find us at Spotify, Apple Podcasts, ThreatVector and Blackberry as well as GooglePlay, Gaana, Himalaya, I Heart Radio and wherever you get your podcasts!   Make sure you Subscribe, Rate and Review!

Host: Shaman Durek - www.shamandurek.com About Guest:  Dr. Judy Ho, Ph. D., ABPP, ABPdN is a triple board certified and licensed Clinical and Forensic Neuropsychologist, a tenured Associate Professor at Pepperdine University, and published author, most recently penning “Stop Self-Sabotage,” published by HarperCollins in August 2019; a book detailing a scientifically driven six-step program which has been translated into 7 additional languages around the world. Dr. Judy maintains a private practice in Manhattan Beach, CA where she specializes in comprehensive neuropsychological assessments and expert witness work. She regularly appears as an expert psychologist on television, podcasts, radio, and contributes to other media including print and electronic periodicals. She is a co-host on the syndicate daytime television talk show “The Doctors,” co-host of CBS’s Face the Truth, and host of The SuperCharged Life podcast produced by Stage 29 Podcast Productions. Dr. Judy Ho is an avid researcher and is a two-time recipient of the National Institute of Mental Health Services Research Award. She hosts an active research program to improve mental health care for high-need populations and is the chair of the Institutional Review Board at Pepperdine University. Her treatment approaches integrate the scientific principles of Cognitive Behavioural Therapy, Acceptance and Commitment Therapy, and Dialectical Behavioural Therapy. She often speaks at national and local events including research, clinical, and corporate conferences and workshops for organizations and schools. Dr. Judy received her bachelor's degrees in Psychology and Business Administration from UC Berkeley, and her masters and doctorate from SDSU/UCSD Joint Doctoral Program in Clinical Psychology. She completed a National Institute of Mental Health sponsored fellowship at UCLA Semel's Institute. https://www.drjudyho.com/ https://www.instagram.com/drjudyho/ https://twitter.com/drjudyho https://www.facebook.com/doctorjudyho https://podcasts.apple.com/us/podcast/supercharged-life-with-dr-judy/id1501219826 https://www.amazon.com/Stop-Self-Sabotage-Motivation-Harness-Willpower/dp/0062874349 Advertisers + Sponsors: BluBlox: www.blublox.com  To get 15% off of purchase use code AWT during check out!  Shaman School: www.theshamanschool.com Tachyon: https://tachyonwellnesssedona.com/product/tachyon-power-rods-6/ Use Discount Code: Shaman for 5% off

Dr. Brewer brings to this episode a wealth of insights about her background, online learning, her specific passions related to academic research, what it means to do research, the purpose of that mysterious Institutional Review Board, and the nature of being a humanistic researcher, and numerous other topics. She brings a true joy to her work and passion for supporting students.  If you're new to research or graduate work, Dr. Brewer's podcast is an outstanding introduction. If you're a seasoned researcher, she offers several insights that bear further reflection. We had a great conversation! Her passion, her kindness, and her accessible approach to higher education made for a truly inspirational conversation. For more on Dr. Brewer go to https://www.linkedin.com/in/laura-c-brewer/For more information about Saybrook University, go to: www.saybrook.edu. You can also learn more about the Saybrook Mind-Body Medicine program by going to https://www.saybrook.edu/areas-of-study/mind-body-medicine/

Yong Bee Lim joins the show to talk about kimchi, rice wine, and building ethical frameworks and institutional review boards for citizen science.

In this episode, we chat with Kevin Gardner. Kevin is a close friend and colleague and has a unique background to learn from. We discuss why Kevin became a nurse, what was his first nursing job and why he chose such a specialty. His eventual departure from emergency medicine and into heart and vascular nursing and finally into his current role as a clinical research trials coordinator. Kevin has a passion for positivity and also brings with him his experiences of leadership with a unique strategy shared in which he learned from the Boy Scouts. Finally, Kevin goes into the levels of evidence (https://libguides.winona.edu/c.php?g=11614&p=61584) and why they are so important for nursing. Other notes include the importance for a nursing model of research within the hospital; utilizing a healthy amount of clinical inquiry; why the Institutional Review Board matters when doing a project of any type; what to possibly expect with your first trauma patient; why it is important to learn how to handle death and more. Kevin Gardner is the Manager of Clinical Research Operations for Heart and Vascular Trials. Focusing of the advancement of heart and vascular medicine and patient safety, Gardner oversees two teams of clinical research professionals who prepare, direct, and coordinate over 60 clinical research projects (over 25 investigator-initiates studies and over 35 sponsored clinical trials). Gardner is a certified emergency nurse by the Board of Certification for Emergency Nursing and certified clinical research coordinator Academy of Clinical Research Professionals. Gardner has served two terms as President of Central Northeast Pennsylvania Chapter of the Association of Clinical Research Professionals and served as Chair of the Nursing Research and Evidenced-Based Practice Council at Penn State Health Milton S. Hershey Medical Center. As Chair, Gardner introduced a journal club that allows the council to provide evidenced-based practice recommendations. Gardner co-authored an article in Applied Nursing Research, “Implementing and Sustaining Evidence Based Practice through a Nursing Journal Club,” (2016) to share the success of the journal club. Gardner is currently working on a master's degree in clinical research operations and management.

In Episode 074, we speed with Dr. Scott Greenberg about numerous health and medical related topics. We initially touch on issues treating the effects of COVID-19 as part of a comprehensive and holistic approach to health, wellness and immune function. We discuss use of nutritional strategies, supplementation and intravenous preparations. We also discuss the use of orthobiologics and regenerative medicine for the treatment of musculoskeletal injuries in both athletes and the general population. Dr. Greenberg identifies applications for use of Platelet Rich Plasma (PRP) injections, as well as the variables around enhancing the efficacy of such treatments.Scott Greenberg, MD specializes in holistic and comprehensive approaches to sports medicine, regenerative orthopedics, chronic pain, arthritis, and post-concussion syndrome. Using methods such as prolotherapy, PRP, and stem cell therapy, he has had great success in treating patients from around the world with a wide variety of problems. A world-renowned integrative and regenerative physician, Dr. Greenberg performs approximately 4,000 procedures each year, and has treated many star/MVP athletes from teams, such as the Philadelphia Flyers, Philadelphia Eagles, Philadelphia Phillies, Philadelphia 76ers, Baltimore Ravens, San Francisco 49ers, New England Patriots, Toronto Blue Jays, and the Colorado Avalanche.Dr. Greenberg is a pioneering leader in developing new stem cell-based therapies. He serves as the chair of the Institutional Review Board of the American Association of Stem Cell Physicians and is a founding board member. He is also a consulting physician for DSM, a leader in regenerative biological medicine. He was a member of the first team to publish a case study to repair a meniscus tear using autologous stem cell therapy. You can find out more information on Dr. Greenberg a via the following links:Website: https://greenbergregen.com/Instagram: https://www.instagram.com/greenbergregen/Facebook: https://www.facebook.com/GreenbergRegen/Twitter: https://twitter.com/GreenbergRegenThe D&D Fitness Radio podcast is available at the following locations for downloadable audio, including: iTunes – https://itunes.apple.com/us/podcast/d-d-fitness-radio-podcast/id1331724217iHeart Radio – https://www.iheart.com/podcast/dd-fitness-radio-28797988/Spreaker.com – https://www.spreaker.com/show/d-and-d-fitness-radios-showYou can reach both Don and Derek at the following locations: Don Saladino: http://www.DonSaladino.com Twitter and Instagram - @DonSaladino YouTube - http://www.youtube.com/donsaladino Derek M. Hansen: http://www.SprintCoach.com Twitter and Instagram - @DerekMHansen YouTube - http://youtube.com/derekmhansen

In Episode 074, we speed with Dr. Scott Greenberg about numerous health and medical related topics. We initially touch on issues treating the effects of COVID-19 as part of a comprehensive and holistic approach to health, wellness and immune function. We discuss use of nutritional strategies, supplementation and intravenous preparations. We also discuss the use of orthobiologics and regenerative medicine for the treatment of musculoskeletal injuries in both athletes and the general population. Dr. Greenberg identifies applications for use of Platelet Rich Plasma (PRP) injections, as well as the variables around enhancing the efficacy of such treatments.Scott Greenberg, MD specializes in holistic and comprehensive approaches to sports medicine, regenerative orthopedics, chronic pain, arthritis, and post-concussion syndrome. Using methods such as prolotherapy, PRP, and stem cell therapy, he has had great success in treating patients from around the world with a wide variety of problems. A world-renowned integrative and regenerative physician, Dr. Greenberg performs approximately 4,000 procedures each year, and has treated many star/MVP athletes from teams, such as the Philadelphia Flyers, Philadelphia Eagles, Philadelphia Phillies, Philadelphia 76ers, Baltimore Ravens, San Francisco 49ers, New England Patriots, Toronto Blue Jays, and the Colorado Avalanche.Dr. Greenberg is a pioneering leader in developing new stem cell-based therapies. He serves as the chair of the Institutional Review Board of the American Association of Stem Cell Physicians and is a founding board member. He is also a consulting physician for DSM, a leader in regenerative biological medicine. He was a member of the first team to publish a case study to repair a meniscus tear using autologous stem cell therapy. You can find out more information on Dr. Greenberg a via the following links:Website: https://greenbergregen.com/Instagram: https://www.instagram.com/greenbergregen/Facebook: https://www.facebook.com/GreenbergRegen/Twitter: https://twitter.com/GreenbergRegenThe D&D Fitness Radio podcast is available at the following locations for downloadable audio, including: iTunes – https://itunes.apple.com/us/podcast/d-d-fitness-radio-podcast/id1331724217iHeart Radio – https://www.iheart.com/podcast/dd-fitness-radio-28797988/Spreaker.com – https://www.spreaker.com/show/d-and-d-fitness-radios-showYou can reach both Don and Derek at the following locations: Don Saladino: http://www.DonSaladino.com Twitter and Instagram - @DonSaladino YouTube - http://www.youtube.com/donsaladino Derek M. Hansen: http://www.SprintCoach.com Twitter and Instagram - @DerekMHansen YouTube - http://youtube.com/derekmhansen

Jeff Abraham is a man dedicated to doing the right thing. After winning a court case against Hyundai who asked him to actively discriminate against female and African American candidates in 1999, he moved to Promescent as CEO, a company founded by his late friend, Dr. Ronald Gilbert. Jeff has continued his legacy by fulfilling his companies dreams in his honor. In addition to this Jeff has spent the last decade advocating sexual health and wellness by educating the public on the importance of intimacy and how to resolve common sexual dysfunctions. Premature Ejaculation Can Cause Erectile Dysfunction Jeff learned that 10% to 15% of erectile dysfunction cases are misdiagnosed cases of premature ejaculation. He clarifies that premature ejaculation is diagnosed when a man suffers from a complete inability to have sex, masturbate, or engage in oral or anal sex for more than 90 seconds without ejaculating. He explains that having clinical PE often causes erectile dysfunction, as when men are aware that PE is going to be the result of sexual play, anxiety can prevent an erection from forming. He says clinicians often diagnose this as ED, but as treating the PE would also cure the ED, a PE diagnosis and treatment is more correct. Healthy Male and Female Climaxes, “The Orgasm Gap.” According to Jeff, a healthy male climaxes after an average of five minutes of sexual stimulation. Meanwhile, he reports that women who are capable of orgasms from penetration take an average of 18 minutes of thrusting to reach orgasm. This gap in climaxes is called the “arousal gap” or “orgasm gap” among sex therapists and neurologists. He points out that even healthy males have good reason to want to last longer, even if they don't meet the diagnostic criteria for PE. He hopes that treatment for longer-lasting sex becomes more respected and acknowledged by the medical community. Causes of Premature Ejaculation Jeff reminds us that premature ejaculation has been needlessly stigmatized. People claim that men ejaculate early due to not caring enough about their partners or not having the mental fortitude to wait longer to orgasm. Jeff admits that some cases of premature ejaculation are psychological in nature, but he lists hypersensitive penile nerves, prostatitis, and low testosterone as some of the physical causes of the condition. Due to the number of physical causes of PE, he hopes that we can reject the notion that men with PE don't care about their partners or that they're mentally weak. PE is a problem with physical roots and as real and treatable as diabetes or cancer. He advocates a combination of behavioral therapy and products like Promescent or SSRIs to help men build confidence and overcome their physical and psychological difficulties. Consequences of Premature Ejaculation Jeff points out that PE destroys men's confidence and limits their ability to satisfy their partners. This lack of confidence, he suggests, isn't confined to the bedroom, but extends to all aspects of life. He calls it the layering effect, which he describes as a sort of chain reaction. In the layering effect he describes, PE can lead to lowered sexual confidence, which leads to being less amorous, which leads to the PE sufferer's partner feeling unattractive due to the lack of sexual attention, and finally leads to a disconnect between the members of the couple. He says he's seen this happen over and over again, all without people realizing that the root of their problems is a single, treatable issue. Jeff advises men not to avoid sex due to PE, pointing out that this leads to men having less control over his own ejaculation, and creates a less pleasant sexual experience than the couple had before. How to Approach Your Partner About PE When approached by women on how to tackle PE with their partners, Jeff suggests setting up a special date night with any sexual accessories you and your partner find enjoyable. He goes on to suggest offering Promescent to your partner as one way to enhance the evening, noting this works better than discussing the problem directly. Jeff shares that this method allows the use of Promescent to be physically and figuratively within your partner's control, a circumstance that he asserts is important for men. When couples use his method, he claims it's often the case that men will try the product, see that it works and improves the experience, and will usually decide to use it more often to enjoy their sex lives consistently. How Promescent Works Unlike its competitor products, which numb the area, this new treatment uses a specific formulation of lidocaine, to create a eutectic formula that can penetrate the outer layer of the skin and be deposited in the fatty tissue underneath the skin, where it can help to better control ejaculation. While the product may have a medicinal aftertaste, he says they're working on neutral, coconut, and citrus flavors to remedy that problem right now. Who Should Use Promescent Jeff emphasizes that the product is for couples, not just men. Sex, he implies, affords a level of intimacy that's important in relationships, and Promescent is just one product that can help that emotional and physical intimacy last longer. He observes that sex is a huge part of life and reiterates that if you're not confident and don't feel good about it, you need to do something or see someone. “Just like we have personal trainers for fitness and coaches for businessmen”, he remarks, “sex therapists are an important part of human health and wellness.” Jeff talks about how men feel the need to hold off climaxing, and he discusses the fact that their desire to last longer provokes a lot of anxiety. He doesn't believe that intimacy should be about anxiety, it should be an enjoyable experience, and making it easier for men to last longer facilitates that for both parties. How Credible Are Promescent's Claims? Jeff is proud to share that Promescent is the most recommended treatment by Urologists today. He's equally proud of the fact that Promescent was found to have statistically significant results in an Institutional Review Board certified study. These elements differentiate their product from the competition by building credibility that can be relayed through physicians or by patients self-diagnosing PE online. Where Can I Get The Product? www.promescent.com eBay.com amazon.com Target (in-store) walmart.com Some independent pharmacies, urologists, and therapists also carry it. Claim your free code for a 15% discount: bettersex15 Resources for Jeff Abraham: https://www.promescent.com/ https://www.promescent.com/expert-reviews-perspectives Discount code: bettersex15 More info: Link to the free guide – Talking About Sex: http://bettersexpodcast.com/talk Join my email list here: http://bettersexpodcast.com/list Book and New Course – https://sexwithoutstress.com Web – https://www.bettersexpodcast.com/ Sex Health Quiz – http://sexhealthquiz.com/ If you're enjoying the podcast and want to be a part of making sure it continues in the future, consider being a patron. With a small monthly pledge, you can support the costs of putting this show together. For as little as $2 per month, you can get advance access to each episode. For just a bit more, you will receive an advance copy of a chapter of my new book. And for $10 per month, you get all that plus an invitation to an online Q&A chat with me once a quarter. Learn more at https://www.patreon.com/bettersexpodcast Better Sex with Jessa Zimmerman https://businessinnovatorsradio.com/better-sex/More info and resources: How Big a Problem is Your Sex Life? Quiz – https://www.sexlifequiz.com The Course – https://www.intimacywithease.com The Book – https://www.sexwithoutstress.com Podcast Website – https://www.intimacywithease.com Access the Free webinar: How to make sex easy and fun for both of you: https://intimacywithease.com/masterclass Secret Podcast for the Higher Desire Partner: https://www.intimacywithease.com/hdppodcast Secret Podcast for the Lower Desire Partner: https://www.intimacywithease.com/ldppodcast

Jeff Abraham is a man dedicated to doing the right thing. After winning a court case against Hyundai who asked him to actively discriminate against female and African American candidates in 1999, he moved to Promescent as CEO, a company founded by his late friend, Dr. Ronald Gilbert. Jeff has continued his legacy by fulfilling his companies dreams in his honor. In addition to this Jeff has spent the last decade advocating sexual health and wellness by educating the public on the importance of intimacy and how to resolve common sexual dysfunctions. Premature Ejaculation Can Cause Erectile Dysfunction Jeff learned that 10% to 15% of erectile dysfunction cases are misdiagnosed cases of premature ejaculation. He clarifies that premature ejaculation is diagnosed when a man suffers from a complete inability to have sex, masturbate, or engage in oral or anal sex for more than 90 seconds without ejaculating. He explains that having clinical PE often causes erectile dysfunction, as when men are aware that PE is going to be the result of sexual play, anxiety can prevent an erection from forming. He says clinicians often diagnose this as ED, but as treating the PE would also cure the ED, a PE diagnosis and treatment is more correct. Healthy Male and Female Climaxes, “The Orgasm Gap.” According to Jeff, a healthy male climaxes after an average of five minutes of sexual stimulation. Meanwhile, he reports that women who are capable of orgasms from penetration take an average of 18 minutes of thrusting to reach orgasm. This gap in climaxes is called the “arousal gap” or “orgasm gap” among sex therapists and neurologists. He points out that even healthy males have good reason to want to last longer, even if they don’t meet the diagnostic criteria for PE. He hopes that treatment for longer-lasting sex becomes more respected and acknowledged by the medical community. Causes of Premature Ejaculation Jeff reminds us that premature ejaculation has been needlessly stigmatized. People claim that men ejaculate early due to not caring enough about their partners or not having the mental fortitude to wait longer to orgasm. Jeff admits that some cases of premature ejaculation are psychological in nature, but he lists hypersensitive penile nerves, prostatitis, and low testosterone as some of the physical causes of the condition. Due to the number of physical causes of PE, he hopes that we can reject the notion that men with PE don’t care about their partners or that they’re mentally weak. PE is a problem with physical roots and as real and treatable as diabetes or cancer. He advocates a combination of behavioral therapy and products like Promescent or SSRIs to help men build confidence and overcome their physical and psychological difficulties. Consequences of Premature Ejaculation Jeff points out that PE destroys men’s confidence and limits their ability to satisfy their partners. This lack of confidence, he suggests, isn’t confined to the bedroom, but extends to all aspects of life. He calls it the layering effect, which he describes as a sort of chain reaction. In the layering effect he describes, PE can lead to lowered sexual confidence, which leads to being less amorous, which leads to the PE sufferer’s partner feeling unattractive due to the lack of sexual attention, and finally leads to a disconnect between the members of the couple. He says he’s seen this happen over and over again, all without people realizing that the root of their problems is a single, treatable issue. Jeff advises men not to avoid sex due to PE, pointing out that this leads to men having less control over his own ejaculation, and creates a less pleasant sexual experience than the couple had before. How to Approach Your Partner About PE When approached by women on how to tackle PE with their partners, Jeff suggests setting up a special date night with any sexual accessories you and your partner find enjoyable. He goes on to suggest offering Promescent to your partner as one way to enhance the evening, noting this works better than discussing the problem directly. Jeff shares that this method allows the use of Promescent to be physically and figuratively within your partner’s control, a circumstance that he asserts is important for men. When couples use his method, he claims it’s often the case that men will try the product, see that it works and improves the experience, and will usually decide to use it more often to enjoy their sex lives consistently. How Promescent Works Unlike its competitor products, which numb the area, this new treatment uses a specific formulation of lidocaine, to create a eutectic formula that can penetrate the outer layer of the skin and be deposited in the fatty tissue underneath the skin, where it can help to better control ejaculation. While the product may have a medicinal aftertaste, he says they’re working on neutral, coconut, and citrus flavors to remedy that problem right now. Who Should Use Promescent Jeff emphasizes that the product is for couples, not just men. Sex, he implies, affords a level of intimacy that’s important in relationships, and Promescent is just one product that can help that emotional and physical intimacy last longer. He observes that sex is a huge part of life and reiterates that if you’re not confident and don’t feel good about it, you need to do something or see someone. “Just like we have personal trainers for fitness and coaches for businessmen”, he remarks, “sex therapists are an important part of human health and wellness.” Jeff talks about how men feel the need to hold off climaxing, and he discusses the fact that their desire to last longer provokes a lot of anxiety. He doesn’t believe that intimacy should be about anxiety, it should be an enjoyable experience, and making it easier for men to last longer facilitates that for both parties. How Credible Are Promescent’s Claims? Jeff is proud to share that Promescent is the most recommended treatment by Urologists today. He’s equally proud of the fact that Promescent was found to have statistically significant results in an Institutional Review Board certified study. These elements differentiate their product from the competition by building credibility that can be relayed through physicians or by patients self-diagnosing PE online. Where Can I Get The Product? www.promescent.com eBay.com amazon.com Target (in-store) walmart.com Some independent pharmacies, urologists, and therapists also carry it. Claim your free code for a 15% discount: bettersex15 Resources for Jeff Abraham: https://www.promescent.com/ https://www.promescent.com/expert-reviews-perspectives Discount code: bettersex15 More info:Link to the free guide – Talking About Sex: http://bettersexpodcast.com/talkJoin my email list here: http://bettersexpodcast.com/listBook and New Course – https://sexwithoutstress.comWeb – https://www.bettersexpodcast.com/Sex Health Quiz – http://sexhealthquiz.com/If you’re enjoying the podcast and want to be a part of making sure it continues in the future, consider being a patron. With a small monthly pledge, you can support the costs of putting this show together. For as little as $2 per month, you can get advance access to each episode. For just a bit more, you will receive an advance copy of a chapter of my new book. And for $10 per month, you get all that plus an invitation to an online Q&A chat with me once a quarter. Learn more at https://www.patreon.com/bettersexpodcastBetter Sex with Jessa Zimmermanhttps://businessinnovatorsradio.com/better-sex/

Jeff Abraham is a man dedicated to doing the right thing. After winning a court case against Hyundai who asked him to actively discriminate against female and African American candidates in 1999, he moved to Promescent as CEO, a company founded by his late friend, Dr. Ronald Gilbert. Jeff has continued his legacy by fulfilling his companies dreams in his honor. In addition to this Jeff has spent the last decade advocating sexual health and wellness by educating the public on the importance of intimacy and how to resolve common sexual dysfunctions. Premature Ejaculation Can Cause Erectile Dysfunction Jeff learned that 10% to 15% of erectile dysfunction cases are misdiagnosed cases of premature ejaculation. He clarifies that premature ejaculation is diagnosed when a man suffers from a complete inability to have sex, masturbate, or engage in oral or anal sex for more than 90 seconds without ejaculating. He explains that having clinical PE often causes erectile dysfunction, as when men are aware that PE is going to be the result of sexual play, anxiety can prevent an erection from forming. He says clinicians often diagnose this as ED, but as treating the PE would also cure the ED, a PE diagnosis and treatment is more correct. Healthy Male and Female Climaxes, “The Orgasm Gap.” According to Jeff, a healthy male climaxes after an average of five minutes of sexual stimulation. Meanwhile, he reports that women who are capable of orgasms from penetration take an average of 18 minutes of thrusting to reach orgasm. This gap in climaxes is called the “arousal gap” or “orgasm gap” among sex therapists and neurologists. He points out that even healthy males have good reason to want to last longer, even if they don’t meet the diagnostic criteria for PE. He hopes that treatment for longer-lasting sex becomes more respected and acknowledged by the medical community. Causes of Premature Ejaculation Jeff reminds us that premature ejaculation has been needlessly stigmatized. People claim that men ejaculate early due to not caring enough about their partners or not having the mental fortitude to wait longer to orgasm. Jeff admits that some cases of premature ejaculation are psychological in nature, but he lists hypersensitive penile nerves, prostatitis, and low testosterone as some of the physical causes of the condition. Due to the number of physical causes of PE, he hopes that we can reject the notion that men with PE don’t care about their partners or that they’re mentally weak. PE is a problem with physical roots and as real and treatable as diabetes or cancer. He advocates a combination of behavioral therapy and products like Promescent or SSRIs to help men build confidence and overcome their physical and psychological difficulties. Consequences of Premature Ejaculation Jeff points out that PE destroys men’s confidence and limits their ability to satisfy their partners. This lack of confidence, he suggests, isn’t confined to the bedroom, but extends to all aspects of life. He calls it the layering effect, which he describes as a sort of chain reaction. In the layering effect he describes, PE can lead to lowered sexual confidence, which leads to being less amorous, which leads to the PE sufferer’s partner feeling unattractive due to the lack of sexual attention, and finally leads to a disconnect between the members of the couple. He says he’s seen this happen over and over again, all without people realizing that the root of their problems is a single, treatable issue. Jeff advises men not to avoid sex due to PE, pointing out that this leads to men having less control over his own ejaculation, and creates a less pleasant sexual experience than the couple had before. How to Approach Your Partner About PE When approached by women on how to tackle PE with their partners, Jeff suggests setting up a special date night with any sexual accessories you and your partner find enjoyable. He goes on to suggest offering Promescent to your partner as one way to enhance the evening, noting this works better than discussing the problem directly. Jeff shares that this method allows the use of Promescent to be physically and figuratively within your partner’s control, a circumstance that he asserts is important for men. When couples use his method, he claims it’s often the case that men will try the product, see that it works and improves the experience, and will usually decide to use it more often to enjoy their sex lives consistently. How Promescent Works Unlike its competitor products, which numb the area, this new treatment uses a specific formulation of lidocaine, to create a eutectic formula that can penetrate the outer layer of the skin and be deposited in the fatty tissue underneath the skin, where it can help to better control ejaculation. While the product may have a medicinal aftertaste, he says they’re working on neutral, coconut, and citrus flavors to remedy that problem right now. Who Should Use Promescent Jeff emphasizes that the product is for couples, not just men. Sex, he implies, affords a level of intimacy that’s important in relationships, and Promescent is just one product that can help that emotional and physical intimacy last longer. He observes that sex is a huge part of life and reiterates that if you’re not confident and don’t feel good about it, you need to do something or see someone. “Just like we have personal trainers for fitness and coaches for businessmen”, he remarks, “sex therapists are an important part of human health and wellness.” Jeff talks about how men feel the need to hold off climaxing, and he discusses the fact that their desire to last longer provokes a lot of anxiety. He doesn’t believe that intimacy should be about anxiety, it should be an enjoyable experience, and making it easier for men to last longer facilitates that for both parties. How Credible Are Promescent’s Claims? Jeff is proud to share that Promescent is the most recommended treatment by Urologists today. He’s equally proud of the fact that Promescent was found to have statistically significant results in an Institutional Review Board certified study. These elements differentiate their product from the competition by building credibility that can be relayed through physicians or by patients self-diagnosing PE online. Where Can I Get The Product? www.promescent.com eBay.com amazon.com Target (in-store) walmart.com Some independent pharmacies, urologists, and therapists also carry it. Claim your free code for a 15% discount: bettersex15 Resources for Jeff Abraham: https://www.promescent.com/ https://www.promescent.com/expert-reviews-perspectives Discount code: bettersex15 More info:Link to the free guide – Talking About Sex: http://bettersexpodcast.com/talkJoin my email list here: http://bettersexpodcast.com/listBook and New Course – https://sexwithoutstress.comWeb – https://www.bettersexpodcast.com/Sex Health Quiz – http://sexhealthquiz.com/If you’re enjoying the podcast and want to be a part of making sure it continues in the future, consider being a patron. With a small monthly pledge, you can support the costs of putting this show together. For as little as $2 per month, you can get advance access to each episode. For just a bit more, you will receive an advance copy of a chapter of my new book. And for $10 per month, you get all that plus an invitation to an online Q&A chat with me once a quarter. Learn more at https://www.patreon.com/bettersexpodcastBetter Sex with Jessa Zimmermanhttps://businessinnovatorsradio.com/better-sex/

Jeff Abraham is a man dedicated to doing the right thing. After winning a court case against Hyundai who asked him to actively discriminate against female and African American candidates in 1999, he moved to Promescent as CEO, a company founded by his late friend, Dr. Ronald Gilbert. Jeff has continued his legacy by fulfilling his companies dreams in his honor. In addition to this Jeff has spent the last decade advocating sexual health and wellness by educating the public on the importance of intimacy and how to resolve common sexual dysfunctions. Premature Ejaculation Can Cause Erectile Dysfunction Jeff learned that 10% to 15% of erectile dysfunction cases are misdiagnosed cases of premature ejaculation. He clarifies that premature ejaculation is diagnosed when a man suffers from a complete inability to have sex, masturbate, or engage in oral or anal sex for more than 90 seconds without ejaculating. He explains that having clinical PE often causes erectile dysfunction, as when men are aware that PE is going to be the result of sexual play, anxiety can prevent an erection from forming. He says clinicians often diagnose this as ED, but as treating the PE would also cure the ED, a PE diagnosis and treatment is more correct. Healthy Male and Female Climaxes, “The Orgasm Gap.” According to Jeff, a healthy male climaxes after an average of five minutes of sexual stimulation. Meanwhile, he reports that women who are capable of orgasms from penetration take an average of 18 minutes of thrusting to reach orgasm. This gap in climaxes is called the “arousal gap” or “orgasm gap” among sex therapists and neurologists. He points out that even healthy males have good reason to want to last longer, even if they don’t meet the diagnostic criteria for PE. He hopes that treatment for longer-lasting sex becomes more respected and acknowledged by the medical community. Causes of Premature Ejaculation Jeff reminds us that premature ejaculation has been needlessly stigmatized. People claim that men ejaculate early due to not caring enough about their partners or not having the mental fortitude to wait longer to orgasm. Jeff admits that some cases of premature ejaculation are psychological in nature, but he lists hypersensitive penile nerves, prostatitis, and low testosterone as some of the physical causes of the condition. Due to the number of physical causes of PE, he hopes that we can reject the notion that men with PE don’t care about their partners or that they’re mentally weak. PE is a problem with physical roots and as real and treatable as diabetes or cancer. He advocates a combination of behavioral therapy and products like Promescent or SSRIs to help men build confidence and overcome their physical and psychological difficulties. Consequences of Premature Ejaculation Jeff points out that PE destroys men’s confidence and limits their ability to satisfy their partners. This lack of confidence, he suggests, isn’t confined to the bedroom, but extends to all aspects of life. He calls it the layering effect, which he describes as a sort of chain reaction. In the layering effect he describes, PE can lead to lowered sexual confidence, which leads to being less amorous, which leads to the PE sufferer’s partner feeling unattractive due to the lack of sexual attention, and finally leads to a disconnect between the members of the couple. He says he’s seen this happen over and over again, all without people realizing that the root of their problems is a single, treatable issue. Jeff advises men not to avoid sex due to PE, pointing out that this leads to men having less control over his own ejaculation, and creates a less pleasant sexual experience than the couple had before. How to Approach Your Partner About PE When approached by women on how to tackle PE with their partners, Jeff suggests setting up a special date night with any sexual accessories you and your partner find enjoyable. He goes on to suggest offering Promescent to your partner as one way to enhance the evening, noting this works better than discussing the problem directly. Jeff shares that this method allows the use of Promescent to be physically and figuratively within your partner’s control, a circumstance that he asserts is important for men. When couples use his method, he claims it’s often the case that men will try the product, see that it works and improves the experience, and will usually decide to use it more often to enjoy their sex lives consistently. How Promescent Works Unlike its competitor products, which numb the area, this new treatment uses a specific formulation of lidocaine, to create a eutectic formula that can penetrate the outer layer of the skin and be deposited in the fatty tissue underneath the skin, where it can help to better control ejaculation. While the product may have a medicinal aftertaste, he says they’re working on neutral, coconut, and citrus flavors to remedy that problem right now. Who Should Use Promescent Jeff emphasizes that the product is for couples, not just men. Sex, he implies, affords a level of intimacy that’s important in relationships, and Promescent is just one product that can help that emotional and physical intimacy last longer. He observes that sex is a huge part of life and reiterates that if you’re not confident and don’t feel good about it, you need to do something or see someone. “Just like we have personal trainers for fitness and coaches for businessmen”, he remarks, “sex therapists are an important part of human health and wellness.” Jeff talks about how men feel the need to hold off climaxing, and he discusses the fact that their desire to last longer provokes a lot of anxiety. He doesn’t believe that intimacy should be about anxiety, it should be an enjoyable experience, and making it easier for men to last longer facilitates that for both parties. How Credible Are Promescent’s Claims? Jeff is proud to share that Promescent is the most recommended treatment by Urologists today. He’s equally proud of the fact that Promescent was found to have statistically significant results in an Institutional Review Board certified study. These elements differentiate their product from the competition by building credibility that can be relayed through physicians or by patients self-diagnosing PE online. Where Can I Get The Product? www.promescent.com eBay.com amazon.com Target (in-store) walmart.com Some independent pharmacies, urologists, and therapists also carry it. Claim your free code for a 15% discount: bettersex15 Resources for Jeff Abraham: https://www.promescent.com/ https://www.promescent.com/expert-reviews-perspectives Discount code: bettersex15 More info:Link to the free guide – Talking About Sex: http://bettersexpodcast.com/talkJoin my email list here: http://bettersexpodcast.com/listBook and New Course – https://sexwithoutstress.comWeb – https://www.bettersexpodcast.com/Sex Health Quiz – http://sexhealthquiz.com/If you’re enjoying the podcast and want to be a part of making sure it continues in the future, consider being a patron. With a small monthly pledge, you can support the costs of putting this show together. For as little as $2 per month, you can get advance access to each episode. For just a bit more, you will receive an advance copy of a chapter of my new book. And for $10 per month, you get all that plus an invitation to an online Q&A chat with me once a quarter. Learn more at https://www.patreon.com/bettersexpodcastBetter Sex with Jessa Zimmermanhttps://businessinnovatorsradio.com/better-sex/

Jeff Abraham is a man dedicated to doing the right thing. After winning a court case against Hyundai who asked him to actively discriminate against female and African American candidates in 1999, he moved to Promescent as CEO, a company founded by his late friend, Dr. Ronald Gilbert. Jeff has continued his legacy by fulfilling his companies dreams in his honor. In addition to this Jeff has spent the last decade advocating sexual health and wellness by educating the public on the importance of intimacy and how to resolve common sexual dysfunctions. Premature Ejaculation Can Cause Erectile Dysfunction Jeff learned that 10% to 15% of erectile dysfunction cases are misdiagnosed cases of premature ejaculation. He clarifies that premature ejaculation is diagnosed when a man suffers from a complete inability to have sex, masturbate, or engage in oral or anal sex for more than 90 seconds without ejaculating. He explains that having clinical PE often causes erectile dysfunction, as when men are aware that PE is going to be the result of sexual play, anxiety can prevent an erection from forming. He says clinicians often diagnose this as ED, but as treating the PE would also cure the ED, a PE diagnosis and treatment is more correct. Healthy Male and Female Climaxes, “The Orgasm Gap.” According to Jeff, a healthy male climaxes after an average of five minutes of sexual stimulation. Meanwhile, he reports that women who are capable of orgasms from penetration take an average of 18 minutes of thrusting to reach orgasm. This gap in climaxes is called the “arousal gap” or “orgasm gap” among sex therapists and neurologists. He points out that even healthy males have good reason to want to last longer, even if they don’t meet the diagnostic criteria for PE. He hopes that treatment for longer-lasting sex becomes more respected and acknowledged by the medical community. Causes of Premature Ejaculation Jeff reminds us that premature ejaculation has been needlessly stigmatized. People claim that men ejaculate early due to not caring enough about their partners or not having the mental fortitude to wait longer to orgasm. Jeff admits that some cases of premature ejaculation are psychological in nature, but he lists hypersensitive penile nerves, prostatitis, and low testosterone as some of the physical causes of the condition. Due to the number of physical causes of PE, he hopes that we can reject the notion that men with PE don’t care about their partners or that they’re mentally weak. PE is a problem with physical roots and as real and treatable as diabetes or cancer. He advocates a combination of behavioral therapy and products like Promescent or SSRIs to help men build confidence and overcome their physical and psychological difficulties. Consequences of Premature Ejaculation Jeff points out that PE destroys men’s confidence and limits their ability to satisfy their partners. This lack of confidence, he suggests, isn’t confined to the bedroom, but extends to all aspects of life. He calls it the layering effect, which he describes as a sort of chain reaction. In the layering effect he describes, PE can lead to lowered sexual confidence, which leads to being less amorous, which leads to the PE sufferer’s partner feeling unattractive due to the lack of sexual attention, and finally leads to a disconnect between the members of the couple. He says he’s seen this happen over and over again, all without people realizing that the root of their problems is a single, treatable issue. Jeff advises men not to avoid sex due to PE, pointing out that this leads to men having less control over his own ejaculation, and creates a less pleasant sexual experience than the couple had before. How to Approach Your Partner About PE When approached by women on how to tackle PE with their partners, Jeff suggests setting up a special date night with any sexual accessories you and your partner find enjoyable. He goes on to suggest offering Promescent to your partner as one way to enhance the evening, noting this works better than discussing the problem directly. Jeff shares that this method allows the use of Promescent to be physically and figuratively within your partner’s control, a circumstance that he asserts is important for men. When couples use his method, he claims it’s often the case that men will try the product, see that it works and improves the experience, and will usually decide to use it more often to enjoy their sex lives consistently. How Promescent Works Unlike its competitor products, which numb the area, this new treatment uses a specific formulation of lidocaine, to create a eutectic formula that can penetrate the outer layer of the skin and be deposited in the fatty tissue underneath the skin, where it can help to better control ejaculation. While the product may have a medicinal aftertaste, he says they’re working on neutral, coconut, and citrus flavors to remedy that problem right now. Who Should Use Promescent Jeff emphasizes that the product is for couples, not just men. Sex, he implies, affords a level of intimacy that’s important in relationships, and Promescent is just one product that can help that emotional and physical intimacy last longer. He observes that sex is a huge part of life and reiterates that if you’re not confident and don’t feel good about it, you need to do something or see someone. “Just like we have personal trainers for fitness and coaches for businessmen”, he remarks, “sex therapists are an important part of human health and wellness.” Jeff talks about how men feel the need to hold off climaxing, and he discusses the fact that their desire to last longer provokes a lot of anxiety. He doesn’t believe that intimacy should be about anxiety, it should be an enjoyable experience, and making it easier for men to last longer facilitates that for both parties. How Credible Are Promescent’s Claims? Jeff is proud to share that Promescent is the most recommended treatment by Urologists today. He’s equally proud of the fact that Promescent was found to have statistically significant results in an Institutional Review Board certified study. These elements differentiate their product from the competition by building credibility that can be relayed through physicians or by patients self-diagnosing PE online. Where Can I Get The Product? www.promescent.com eBay.com amazon.com Target (in-store) walmart.com Some independent pharmacies, urologists, and therapists also carry it. Claim your free code for a 15% discount: bettersex15 Resources for Jeff Abraham: https://www.promescent.com/ https://www.promescent.com/expert-reviews-perspectives Discount code: bettersex15 More info:Link to the free guide – Talking About Sex: http://bettersexpodcast.com/talkJoin my email list here: http://bettersexpodcast.com/listBook and New Course – https://sexwithoutstress.comWeb – https://www.bettersexpodcast.com/Sex Health Quiz – http://sexhealthquiz.com/If you’re enjoying the podcast and want to be a part of making sure it continues in the future, consider being a patron. With a small monthly pledge, you can support the costs of putting this show together. For as little as $2 per month, you can get advance access to each episode. For just a bit more, you will receive an advance copy of a chapter of my new book. And for $10 per month, you get all that plus an invitation to an online Q&A chat with me once a quarter. Learn more at https://www.patreon.com/bettersexpodcastBetter Sex with Jessa Zimmermanhttps://businessinnovatorsradio.com/better-sex/

The human body was created with amazing restorative, healing and regenerative powers! Stem cells, which are found in fat cells and bone marrow, play a vital role in cellular regeneration and healing. When an injury occurs, stem cells produce exosomes that communicate restorative signals to the injured cells. Stem Cell Exosome therapy is a safe and affordable alternative to stem cell therapy and has multiple uses including: Immune Disorders, Neurotransmitter Issues (Dementia, Alzheimer’s, etc.), Multiple Sclerosis, Rheumatoid Arthritis, Parkinson’s Disease, and many others. In addition, exosome therapy can be used to help maintain youth, hair growth, romantic function, joint health, and general healthy upkeep of the body. Hotze Health & Wellness Center is excited be on the cutting edge of this technology and is proud to be the FIRST to submit studies to the Institutional Review Board on the benefits of Exosomes! Watch the podcast now and learn more about the natural restorative powers of exosome therapy so you can enjoy a better quality of life! Watch now and subscribe to our podcasts at www.HotzePodcast.com If you have any of the signs and symptoms mentioned on this podcast, take our free symptom checker test at https://www.hotzehwc.com/symptom-checker/

The human body was created with amazing restorative, healing and regenerative powers! Stem cells, which are found in fat cells and bone marrow, play a vital role in cellular regeneration and healing. When an injury occurs, stem cells produce exosomes that communicate restorative signals to the injured cells. Stem Cell Exosome therapy is a safe and affordable alternative to stem cell therapy and has multiple uses including: Immune Disorders, Neurotransmitter Issues (Dementia, Alzheimer’s, etc.), Multiple Sclerosis, Rheumatoid Arthritis, Parkinson’s Disease, and many others. In addition, exosome therapy can be used to help maintain youth, hair growth, romantic function, joint health, and general healthy upkeep of the body. Hotze Health & Wellness Center is excited be on the cutting edge of this technology and is proud to be the FIRST to submit studies to the Institutional Review Board on the benefits of Exosomes! Watch the podcast now and learn more about the natural restorative powers of exosome therapy so you can enjoy a better quality of life! Watch now and subscribe to our podcasts at www.HotzePodcast.com If you have any of the signs and symptoms mentioned on this podcast, take our free symptom checker test at https://www.hotzehwc.com/symptom-checker/

I’m thrilled to have made friends with Dr. Amy Laura Hall. Not only is she back on the podcast to talk about Stanley Hauerwas’ influence on her work and theology, she’ll be our special guest in June at our annual live podcast at Annual Conference in Roanoke, Va. Amy Laura Hall was named a Henry Luce III Fellow in Theology for 2004-2005 and has received funding from the Lilly Foundation, the Josiah Trent Memorial Foundation, the American Theological Library Association, the Child in Religion and Ethics Project, the Pew Foundation and the Project on Lived Theology.At Duke University, Professor Hall has served on the steering committee of the Genome Ethics, Law, and Policy Center and as a faculty member for the FOCUS program of the Institute on Genome Sciences and Policy. She has served on the Duke Medical Center’s Institutional Review Board and as an ethics consultant to the V.A. Center in Durham. She served as a faculty adviser with the Duke Center for Civic Engagement (under Leela Prasad), on the Academic Council, and as a faculty advisor for the NCCU-Duke Program in African, African American & Diaspora Studies. She currently teaches with and serves on the faculty advisory board for Graduate Liberal Studies and serves as a core faculty member of the Focus Program in Global Health.Professor Hall was the 2017 Scholar in Residence at Foundry United Methodist Church in Washington D.C., served on the Bioethics Task Force of the United Methodist Church, and has spoken to academic and ecclesial groups across the U.S. and Europe. An ordained elder in the United Methodist Church, Hall is a member of the Rio Texas Annual Conference. She has served both urban and suburban parishes. Her service with the community includes an initiative called Labor Sabbath, an effort with the AFL-CIO of North Carolina to encourage congregations of faith to talk about the usefulness of labor unions, and, from August 2013 to June 2017, a monthly column for the Durham Herald-Sun. Professor Hall organized a conference against torture in 2011, entitled “Toward a Moral Consensus Against Torture,” and a “Conference Against the Use of Drones in Warfare” October 20-21, 2017. In collaboration with the North Carolina Council of Churches and the United Methodist Church, she organized a workshop with legal scholar Richard Rothstein held October, 2018.Amy Laura Hall is the author of four books: Kierkegaard and the Treachery of Love, Conceiving Parenthood: The Protestant Spirit of Biotechnological Reproduction, Writing Home with Love: Politics for Neighbors and Naysayers, and Laughing at the Devil: Seeing the World with Julian of Norwich. She has written numerous scholarly articles in theological and biomedical ethics. Recent articles include "The Single Individual in Ordinary Time: Theological Engagements in Sociobiology," which was a keynote lecture given with Kara Slade at the Society for the Study of Christian Ethics in 2012, and "Torture and American Television," which appeared in the April 2013 issue of Muslim World, a volume that Hall guest-edited with Daniel Arnold. Her essay “Love in Everything: A Brief Primer to Julian of Norwich" appeared in volume 32 of The Princeton Seminary Bulletin. Word and World published her essay on heroism in the Winter 2016 edition, and her essay "His Eye Is on the Sparrow: Collectivism and Human Significance" appeared in a volume entitled Why People Matter with Baker Publishing. Her forthcoming essays include a new piece on Kierkegaard and love for The T&T Clark Companion to the Theology of Kierkegaard, to be published by Bloomsbury T&T Clark.Laughing at the Devil was the focus of her 2018 Simpson Lecture at Simpson College in Iowa and has been chosen for the 2019 Virginia Festival of the Book. She continues work on a longer research project on masculinity and gender anxiety in mainstream, white evangelicalism.

I’m thrilled to have made friends with Dr. Amy Laura Hall. Not only is she back on the podcast to talk about Stanley Hauerwas’ influence on her work and theology, she’ll be our special guest in June at our annual live podcast at Annual Conference in Roanoke, Va. Amy Laura Hall was named a Henry Luce III Fellow in Theology for 2004-2005 and has received funding from the Lilly Foundation, the Josiah Trent Memorial Foundation, the American Theological Library Association, the Child in Religion and Ethics Project, the Pew Foundation and the Project on Lived Theology.At Duke University, Professor Hall has served on the steering committee of the Genome Ethics, Law, and Policy Center and as a faculty member for the FOCUS program of the Institute on Genome Sciences and Policy. She has served on the Duke Medical Center’s Institutional Review Board and as an ethics consultant to the V.A. Center in Durham. She served as a faculty adviser with the Duke Center for Civic Engagement (under Leela Prasad), on the Academic Council, and as a faculty advisor for the NCCU-Duke Program in African, African American & Diaspora Studies. She currently teaches with and serves on the faculty advisory board for Graduate Liberal Studies and serves as a core faculty member of the Focus Program in Global Health.Professor Hall was the 2017 Scholar in Residence at Foundry United Methodist Church in Washington D.C., served on the Bioethics Task Force of the United Methodist Church, and has spoken to academic and ecclesial groups across the U.S. and Europe. An ordained elder in the United Methodist Church, Hall is a member of the Rio Texas Annual Conference. She has served both urban and suburban parishes. Her service with the community includes an initiative called Labor Sabbath, an effort with the AFL-CIO of North Carolina to encourage congregations of faith to talk about the usefulness of labor unions, and, from August 2013 to June 2017, a monthly column for the Durham Herald-Sun. Professor Hall organized a conference against torture in 2011, entitled “Toward a Moral Consensus Against Torture,” and a “Conference Against the Use of Drones in Warfare” October 20-21, 2017. In collaboration with the North Carolina Council of Churches and the United Methodist Church, she organized a workshop with legal scholar Richard Rothstein held October, 2018.Amy Laura Hall is the author of four books: Kierkegaard and the Treachery of Love, Conceiving Parenthood: The Protestant Spirit of Biotechnological Reproduction, Writing Home with Love: Politics for Neighbors and Naysayers, and Laughing at the Devil: Seeing the World with Julian of Norwich. She has written numerous scholarly articles in theological and biomedical ethics. Recent articles include "The Single Individual in Ordinary Time: Theological Engagements in Sociobiology," which was a keynote lecture given with Kara Slade at the Society for the Study of Christian Ethics in 2012, and "Torture and American Television," which appeared in the April 2013 issue of Muslim World, a volume that Hall guest-edited with Daniel Arnold. Her essay “Love in Everything: A Brief Primer to Julian of Norwich" appeared in volume 32 of The Princeton Seminary Bulletin. Word and World published her essay on heroism in the Winter 2016 edition, and her essay "His Eye Is on the Sparrow: Collectivism and Human Significance" appeared in a volume entitled Why People Matter with Baker Publishing. Her forthcoming essays include a new piece on Kierkegaard and love for The T&T Clark Companion to the Theology of Kierkegaard, to be published by Bloomsbury T&T Clark.Laughing at the Devil was the focus of her 2018 Simpson Lecture at Simpson College in Iowa and has been chosen for the 2019 Virginia Festival of the Book. She continues work on a longer research project on masculinity and gender anxiety in mainstream, white evangelicalism.

Claudia Cragg (@ClaudiaCragg) speaks here with , about his newest book, #WhoSaysYoureDead Medical & Ethical Dilemmas for the Curious & Concerned from @AlgonquinBooks Appel presents an invigorating way to think about vital health and ethical issues that many will confront as individuals, or we as a society must reckon with together. Drawing upon the author’s two decades teaching medical ethics, as well as his work as a practicing psychiatrist, this profound and addictive little book offers up challenging ethical dilemmas and asks readers, What would you do? Appel is an , , , ,   and . He is best known for his , his work as a , and his writing in the fields of reproductive ethics, ,  and . Appel's novel  won the  in 2012. He teaches bioethics at the Icahn School of Medicine at Mount Sinai, where he is Director of Ethics Education in Psychiatry and a member of the Institutional Review Board. He is also an attending psychiatrist in the Mount Sinai Healthcare System. He holds a medical degree from Columbia University’s College of Physicians and Surgeons, a law degree from Harvard Law School, and a master’s in bioethics from the Alden March Bioethics Institute of Albany Medical College. A frequent lecturer, his essays and columns relating to bioethics have appeared in the New York Times, the Chicago Tribune, the San Francisco Chronicle, the Huffington Post, and Education Update. Dr. Appel has also published novels and prize-winning short stories.

Do you understand the difference between significant risk and nonsignificant risk when it comes to the development and design of your medical devices? It's important to classify devices properly, and the difference between SR and NSR is not always well-defined. Today, our guest will help medical device companies differentiate between these two classifications. Mike Drues, president of Vascular Sciences, has been a frequent guest on our show. He's an expert in compliance, medical technology and regulatory compliances. Mike works regularly with the FDA, Canada Health, and other international regulatory agencies, and today he is sharing his insight on SR vs. NSR, as well as how this affects your development processes for your medical devices. Some of the topics you'll hear about today include: - The difference between significant and nonsignificant risk, and how you can differentiate between the two. - Who decides whether a device has a significant or nonsignificant risk. (Hint: It's not the FDA!) - Tips on analyzing, documenting, and finding experts to help you determine whether you are dealing with SR and NSR, as well as tips on notifying the FDA through the pre-submission process. - Information about the Institutional Review Board and how they are involved in the SR vs. NSR differentiation. - Thoughts on running clinical trials outside of the USA: advantages, disadvantages, and practicalities.

Kathryn interviews Jonathan Mooney, NY Times best-selling author of “Normal Sucks: How to Live, Learn, and Thrive Outside the Lines.” Diagnosed with dyslexia and ADHD as a kid, Mooney didn't learn to read until he was twelve; he often heard that he was lazy and stupid and would probably end up homeless or in jail. He realized he wasn't the problem - the educational system and society's concept of normal were. His work has been featured in the NY Times, LA Times, Chicago Tribune, USA Today, HBO, NPR, ABC News, NY Magazine, Washington Post and the Boston Globe. Kathryn also interviews Bioethicist & Mount Sinai Psychiatrist Jacob M. Appel MD, JD, author of “Who Says You're Dead?: Medical & Ethical Dilemmas for the Curious & Concerned.” Dr. Appel poses bioethical questions, asking readers to play doctor and decide what they would do if confronted with the dilemma. He's an attending psychiatrist in the Mount Sinai Healthcare System and is a member of the Institutional Review Board.

Kathryn interviews Jonathan Mooney, NY Times best-selling author of “Normal Sucks: How to Live, Learn, and Thrive Outside the Lines.” Diagnosed with dyslexia and ADHD as a kid, Mooney didn't learn to read until he was twelve; he often heard that he was lazy and stupid and would probably end up homeless or in jail. He realized he wasn't the problem - the educational system and society's concept of normal were. His work has been featured in the NY Times, LA Times, Chicago Tribune, USA Today, HBO, NPR, ABC News, NY Magazine, Washington Post and the Boston Globe. Kathryn also interviews Bioethicist & Mount Sinai Psychiatrist Jacob M. Appel MD, JD, author of “Who Says You're Dead?: Medical & Ethical Dilemmas for the Curious & Concerned.” Dr. Appel poses bioethical questions, asking readers to play doctor and decide what they would do if confronted with the dilemma. He's an attending psychiatrist in the Mount Sinai Healthcare System and is a member of the Institutional Review Board.

Frank Pasciuti, Ph.D. talks about his new book Chrysalis Crisis: How life Ordeals Can Lead to Personal & Spiritual Transformation Seeking personal and spiritual growth is the underpinning of human experience. We are always seeking information to make our lives easier while we seek a deeper understanding of why we are here. Frank uses the Chrysalis as a metaphor for our lives. The caterpillar creates a cocoon and then struggles to set itself free as it morphs into a butterfly. While not an easy task, the end result is a beautiful butterfly free to experience a life of its own choosing. Humans can do this too! We talk about How a crisis can be our best opportunity for personal and spiritual growthGaining strength from a crisisTen broad areas of human growthHow to master the physical worldHow near-death experiences create growthUnderstanding deathTranspersonal developmentEvolution and expansion of consciousnessIntuitive CrisisSpirituality is not religionPsychopath - born or createdEverything changes and there will always be a certain amount of suffering Frank Pasciuti, Ph.D. is a licensed clinical psychologist and certified hypnotherapist in private practice in Charlottesville, Virginia. He is the founder and president of Associated Clinicians of Virginia, which provides psychotherapy and organizational development services to individuals and businesses. Dr. Pasciuti is chairman of the Institutional Review Board at the Monroe Institute in Faber, Virginia, and he collaborates on research related to NDE's, psychic phenomena, and the survival of consciousness at the Division of Perceptual Studies, a research unit of the Department of Psychiatry and Neurobehavioral Sciences at the University of Virginia school of medicine. www.frankpasciuti.com

Kathryn interviews Jonathan Mooney, NY Times best-selling author of “Normal Sucks: How to Live, Learn, and Thrive Outside the Lines.” Diagnosed with dyslexia and ADHD as a kid, Mooney didn't learn to read until he was twelve; he often heard that he was lazy and stupid and would probably end up homeless or in jail. He realized he wasn't the problem - the educational system and society's concept of normal were. His work has been featured in the NY Times, LA Times, Chicago Tribune, USA Today, HBO, NPR, ABC News, NY Magazine, Washington Post and the Boston Globe. Kathryn also interviews Bioethicist & Mount Sinai Psychiatrist Jacob M. Appel MD, JD, author of “Who Says You're Dead?: Medical & Ethical Dilemmas for the Curious & Concerned.” Dr. Appel poses bioethical questions, asking readers to play doctor and decide what they would do if confronted with the dilemma. He's an attending psychiatrist in the Mount Sinai Healthcare System and is a member of the Institutional Review Board.

Kathryn interviews Jonathan Mooney, NY Times best-selling author of “Normal Sucks: How to Live, Learn, and Thrive Outside the Lines.” Diagnosed with dyslexia and ADHD as a kid, Mooney didn't learn to read until he was twelve; he often heard that he was lazy and stupid and would probably end up homeless or in jail. He realized he wasn't the problem - the educational system and society's concept of normal were. His work has been featured in the NY Times, LA Times, Chicago Tribune, USA Today, HBO, NPR, ABC News, NY Magazine, Washington Post and the Boston Globe. Kathryn also interviews Bioethicist & Mount Sinai Psychiatrist Jacob M. Appel MD, JD, author of “Who Says You're Dead?: Medical & Ethical Dilemmas for the Curious & Concerned.” Dr. Appel poses bioethical questions, asking readers to play doctor and decide what they would do if confronted with the dilemma. He's an attending psychiatrist in the Mount Sinai Healthcare System and is a member of the Institutional Review Board.

One oncologist provides his take on responding to "compassionate use" requests TRANSCRIPT The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care, and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement. [DR. LIDIA SCHAPIRA] Welcome to JCO's Cancer Stories-- The Art of Oncology, brought to you by the ASCO Podcast Network, a collection of nine programs covering a range of educational and scientific content, and offering enriching insight into the world of cancer care. You can find all of the shows, including this one, at podcast.asco.org. [GREG GUTHRIE] "Compassion and Compassionate Use," by David J. Einstein. The email came down to this. This patient is running out of options, and he and his family are starting to think outside the box. Two months prior, the sender was my co-fellow. Now, after a blissful vacation month entirely unplugged from oncology, he and I were junior attending physicians, launched into the dual frontlines of inpatient and outpatient oncology. He was staffing the consult service, I the inpatient oncology service, both of us simultaneously trying to keep our backburner outpatient clinics and research projects from boiling over. He was letting me know about my newest admission, a patient with advanced choriocarcinoma, which was ostensibly within my area of expertise of genitourinary cancers. During years of residency training, we had learned to eyeball patients and differentiate sick from not sick-- or really, those who might be imminently dying from those who were OK for now. As oncology fellows, we recognized a new group-- the patients who seemed to be imminently dying on paper, but in person looked amazingly normal. The patient referred to in the email was such a patient-- an energetic engineer in his 50's, with a more than slight Boston accent, despite his years in California and Texas, and plenty of Red Sox gear to match. On paper, he was in dire shape, with treatment-resistant advanced cancer and increasing toxicities of treatment. The patient and this family had taken on his disease with a battle mentality that works for some and makes others cringe. After multiple rounds of chemotherapy, resections, and radiation treatments failed to cure his disease, he moved on to the high-dose chemotherapy with autologous stem cell rescue that is the standard of care in this setting. If some chemotherapy is good, more is better. However, he eventually exhausted his supply of stem cells, still without having achieved remission. Time to think outside the box, turning to his identical twin brother as a source of new stem cells. The patient proceeded to a last-ditch effort at high-dose chemotherapy, this time with syngeneic transplantation. It worked, for approximately three months. Despite the most intensive efforts, his disease kept bouncing back. At this point, it was clear that chemotherapy would only transiently suppress his cancer, but not cure it. Meanwhile, his treatments left him with hearing loss severe enough to require hearing aids, poor kidney function, foot numbness, and bone marrow that, even on imaging, looked exhausted, plus prolonged cytopenias to prove it. What could be done? This patient and his family had crossed the country in search of an outside the box treatment that might offer him the benefit that stand treatments had not. We are used to patients looking online for new diets and complementary medicines. We understand that this is a way to seek an active part in their care, when they otherwise feel like passive recipients. The patient and his family had gone further, identifying a clinical trial available at our hospital that they desperately wanted to join. But the trial was in a different tumor type. And moreover, he would not be a candidate for any of the trial, given his accumulated treatment-related toxicities. Undaunted, his sister found an online poster from our peer institution across the street, describing a novel compound used to treat a patient with his disease, with the resulting and seemingly miraculous remission. Again, we are accustomed to the patient who brings in the latest online research to an appointment. Sometimes it is not scientifically valid. Sometimes it is valid, but not applicable to the situation. And occasionally, it is both valid and applicable, and actually does result in a treatment change. As I scrutinized the information the patient's sister provided, it actually seemed both possibly valid and applicable. I could find no obvious toxicity that precluded use of this drug. And yet, it was early in testing, far from full approval. "What about compassionate use?" the family asked. Compassionate use was a term I had only heard spoken of dismissively. We oncologists prided ourselves on always being compassionate, whether we were administering therapies or stopping them. Treating outside of standard care without the structure of a research study is dangerous territory. But this concept has a popular appeal. Who wouldn't want to try anything that could help in a desperate situation? Recently, proponents of so-called "right to try" legislation claimed that the Food and Drug Administration, or FDA, regulation was interfering with patients' access to experimental therapies outside of trials. The FDA replied that they approved 99% of expanded access requests. Indeed, compared with the regulatory hurdles I faced from my own institution, I discovered that the FDA was the smallest barrier of all. As I learned, creating a single-patient investigational new drug application for compassionate use was the ultimate in personalized medicine-- a clinical trial created for one person. In fact, it was a desperate hope thrown into the slow-moving and opaque gears of our clinical research regulation, only to be chewed into a million track changes documents and flurries of emails. I was rapidly assembling a trial protocol to use highly experimental therapy into patients whose disease was bound to cause suffocation or bleeding at any moment. It was a terrifying, anxiety-provoking situation for a physician, patient, and family alike. I felt caught between-- on the one side an eager and aggressive patient who wanted to sign anything, cover any cost, just to have a shot at a miracle, and on the other side, a process purposefully built to be as cautious as possible. I caught myself erupting in frustration, unfairly lashing out at the secretary who emailed me with Institutional Review Board, or IRB, edits on an informed consent form that the patient would never read. Just as we were getting ready to sign this consent form, the patient's disease was making itself more plainly visible in the form of a bleeding superficial metastasis. Now, another regulatory catastrophe-- between the bleeding lesion and the need for radiation, he was ineligible for the trial because of the strictly-worded inclusion criteria used in the rigid old protocol. Time for yet another urgent amendment pleading for the IRB not to hold me to the rules that I myself had provided. When, after months of work, the patient received a single dose of the study treatment, we all felt like we had climbed Everest. All along the way, I tried to frame this as a victory in and of itself, hoping he would die feeling he had tried everything. But he, of course, wanted to live, through sheer will and perseverance. And I'll admit, a small portion of me wanted to prove my doubts wrong, to be the junior attending daring enough to try something audacious and land a huge unconventional win. It was not to be. After many tense clinic appointments and late-night calls during my drive home, our last conversations unfortunately occurred in the intensive care unit. With the rush of the high flu nasal cannula as background white noise, I told the patient that his disease was not even responding to the chemotherapy I had tried a week ago in an ultra last-ditch effort to get him back to the study drug. I could not pull him back from the edge of that ultimate cliff. Although I had tried hard to have the appropriate discussions with the patient and his family on many occasions, trying to refocus their hopes on spending good time together, freedom from pain and breathlessness, and another day outside the infusion area and the oncology ward, I knew they felt I had failed them, that maybe pushing just a little harder would have made the difference. One morning, I awoke to an email from the intensive care unit resident, letting me know that the patient had died that night. Thankfully, we had agreed that aggressive interventions in his dying moments would be even less effective than our chemotherapies. And instead, he had received much more effective supportive care. I let out a breath of simultaneous relief and regret. I knew this moment had been coming, of course. I disagreed with my patient and his family about how to prepare for it. But my team and I had tried to make the patient and his family feel that every effort had been made on his behalf. I felt the failure, not in his inevitable death, but in never arriving at a moment of shared celebration for our combined efforts, when we could say together, even in that intensive care unit room, it was all worth it. And when I went to contact his wife and sister, I never heard from them again. I certainly do not fault them for not returning my calls or emails during the midst of intense grief. Yet I never heard whether they felt that our compassionate use of a single dose of experimental treatment had helped or hurt. He went from being my all-consuming focus to a vanished spirit. And I had to wonder whether the family's silence gave me my answer. The recent right to try legislation cleared the US Senate last year and the House of Representatives in March alone mostly partisan lines. Opponents, including representatives from the American Society of Clinical Oncology, as well as the American Cancer Society, pointed out the value of FDA oversight and the existing pathway for access to experimental therapies outside of clinical trials. Regardless of the fact that this legislation does not affect the institutional barriers I encountered, I do wonder whether it will inspire a growing number of desperate patients to exercise their right to try. How should oncologists respond? Except in the cases of a drug that seems to have particularly exciting preclinical justification or early clinical data, I suspect most will advise their patients with advanced cancer to stick to more trodden territory, to try accepted anticancer therapies when they are judged to be reasonable and to switch to supportive care alone when the risk seems to outweigh the benefit, individualized to patient preferences. As we continue to chase progress in cancer, Wachter recently wrote, let's be sure that we don't rob dying patients of a smaller, more subtle miracle: a death with dignity and grace, relatively free from pain and discomfort. But there will always be the patients like mine: unsatisfied to do nothing, as much as we try to reinforce that intensive supportive care is far from nothing. I recall the words of another oncologist who had seen the patient for a second opinion. These patients with refractory testicular cancer die with the chemo going in, chemotherapy, or perhaps increasingly, experimental drugs. If we are to routinely offer such patients access to experimental drugs outside of clinical trials, then we will need to address several issues in advance. First, federal and local regulatory burdens will have to be substantially lower. We will need to simplify the process of writing a protocol, obtaining a IRB approval, and amending the protocol as clinical circumstances evolve. As a word of advice, oncologists embarking on such a process should be careful about recycling protocols written for standard trials. In particular, because these protocols are designed around a specific patient, the inclusion and exclusion criteria should be minimal. Second, directors of clinical trial programs will have to decide whether their operations are capable of diverting resources from standard trials to these urgent and unfunded projects. Finally and most importantly, individual clinicians will have to develop strong end-of-life communication skills to help frame a shared decision-making process properly. And they may even have to make especially difficult decisions about when to exercise a right to deny such requests. I hope that all of my patients will feel that I have treated them compassionately and with the tools best suited to their situation, whether or not this includes compassionate use of unproven therapies. And I hope that my patient did indeed feel that we left no stone unturned and that he felt some small satisfaction in this. [DR. LIDIA SCHAPIRA] Welcome to Cancer Stories. I'm Lidia Schapira, editorial consultant for the Journal of Clinical Oncology's Art of Oncology, and the host for this podcast. My guest today is Dr. David Einstein, a medical oncologist at Beth Israel Deaconess Medical Center in Boston and an instructor at Harvard Medical School. Dr. Einstein is the author of "Compassion and Compassionate Use." David, welcome to our program. [DR. DAVID EINSTEIN] Well, thanks so much for having me. It's a real honor. [DR. LIDIA SCHAPIRA] It's terrific to have you. Tell me a little bit about your writing. Have you always been a writer? [DR. DAVID EINSTEIN] Yeah, actually this goes back to my intern year, oddly enough, when I was signing out a patient to the night float intern. And I was telling the story of what had happened that day. And the night float intern told me, wow, that's a really interesting story. And that was the first time I had ever thought of translating what I did on a daily basis onto paper. And that was a very moving experience, which I'm happy to share, as well. But that sort of got me started about reflecting on patients and key moments in my medical practice. And now, all these years later, and being a first-year attending, I'm on a similar learning curve. And I wanted to, again, take an opportunity to step back and reflect on what it was that I was doing. [DR. LIDIA SCHAPIRA] And can you tell the listeners a little bit of what that reflecting process is like for you? [DR. DAVID EINSTEIN] Yeah. So I think that, a lot of times, these things seem to pop up at unexpected times, so on the commute home or the shower in the morning. And it's sort of these nagging thoughts that just keep coming into your head. And eventually, they've been bouncing around for long enough that you feel the need to actually put that down on paper and reflect on what it is that your mind's trying to work out. [DR. LIDIA SCHAPIRA] And do you have a writing group, or is this pretty much a solitary activity for you? [DR. DAVID EINSTEIN] I'd say fairly solitary. But oftentimes, it's sparked by discussions with colleagues. And then also, once I've actually put something down on paper, I very much solicit colleagues' input, just as I would for any kind of difficult medical case or difficult psychosocial case. And so on everything that I've written, I've always tried to circulate it among a couple of trusted colleagues for their input, as well. [DR. LIDIA SCHAPIRA] And so if this was, perhaps, sparked by a difficult clinical scenario, can you tell us a little bit about what made this particular case so challenging and difficult for you? [DR. DAVID EINSTEIN] Yeah. I think that, early on in elementary school, we're sort of taught that stories are conflict and resolution. And the really unique thing about this situation was that there were a variety of conflicts and really very little resolution. And that, I think, was what made it keep recurring in my mind as something that I really felt the need to reflect on. [DR. LIDIA SCHAPIRA] Tell us a little bit about this patient and how you were drawn in in his very desperate fight and his wish to have a shot at a miracle. [DR. DAVID EINSTEIN] Yeah, so again, this was early on in my attending career. So you've got all sorts of your own anxieties anyway about staffing an inpatient service and keeping an outpatient clinic going and starting up research projects. And as I'm starting, I hear from my colleague about this very sick gentleman. But I go in to meet him, and he looks like an ordinary guy off the street. And it was sort of hard to reconcile those two things at first. And he always traveled as a group. He had this whole support team that had been with him through everything. So his wife was always bedside. She was a high school sweetheart. And his sister was always bedside, and she was actually a biotech lawyer. And he was an engineer. And I think, especially between the lawyer and the engineer, they had a very go-getter attitude. They did their own research. They came up with treatment plans. They really were extremely thoughtful people, and also, in a sense, very aggressive people to have pushed through everything that he had already been through even before I met him. [DR. LIDIA SCHAPIRA] And that resonated with you, as well, right, the idea that, here is somebody who has done all of this research and put in this incredible effort. And then what happened? [DR. DAVID EINSTEIN] Right. So it's not so dissimilar from what we as physicians do, and I very much respected their efforts. They came to us, clearly, after all standard treatments, and even some non-standard treatments, had not gotten the hoped for result of a cure. And that's one of the things that makes testis cancer so difficult, of course, is that, we aim for cure so much of the time. And those times where we fail or the disease overwhelms us, that's that much harder to prepare for. And so I started looking over other palliative chemotherapy regimens and the toxicities and the relative benefits and response rates of all of these. And the more I thought about it, the more I thought, what is this a bridge to? What am I trying to get out of any of this? And with them, I started to explore the ideas of targeted therapy, which we've heard so much about, and immune therapies, which he had actually already tried. And we got to that point where I was saying, there is no treatment, no matter how efficacious, that's going to work with what I see in front of me, with all these toxicities. And they processed that. But they came back, and after doing a little more research, came up with this case report from just across the street, about a patient with a similar disease getting some long-term response out of an experimental drug, which had completed Phase 1 testing. And so they said, how do we get this? And I looked through the traditional routes of trying to get him on trial or trying to get exceptions. And the more I looked, the more I ran into roadblocks. And eventually, they asked me about this compassionate use concept, which I had heard only vaguely about, and certainly no personal experience with that. And as I started asking around among my colleagues, I found out that, really, very few people have much experience with this, other than one other at our institution. And so it really was sort of reinventing the wheel, as far as treatment protocol. [DR. LIDIA SCHAPIRA] It sounds like this gentlemen, if we are to sort of give a title to this scenario, is one of those, as you say, engaging people who is a fighter, but for whom death is really not an option. Am I right in saying that, that they just would not have that conversation with you? They were really searching for something that could be done, an action solution to this problem. [DR. DAVID EINSTEIN] Right. They were very intelligent people. They knew that he was in a dire situation. I try to use the word death and dying in my conversations to be as clear as possible. And they weren't able to process that and talk about that. But it was very clear that this was not the kind of patient who would feel comfortable going home and focusing on symptoms. And in a sense, there wasn't much to focus on, until the end really came. Because with these diseases, they just progress so rapidly. And so for him, he very clearly was on the side of, I would rather die in a hospital with treatment toxicity, even if none of that stuff helped me, rather than-- if you can't tell me that any of these treatments are going to help, then I'd rather not be here. Which I would say a good 3/4 of my patients are a little bit more in the latter camp. And there's a point at which everyone sort of feels like, let's do whatever is in our power to work on the symptoms of your disease and stop assaulting you with therapies that might not help and could certainly hurt. He was very clearly on the polar opposite end of that spectrum. And for him, I think, a little bit of his engineering personality, it was important to think up a new way of treating this disease, and to go for that incredibly slim shot of a long-term remission, however slim that might be. [DR. LIDIA SCHAPIRA] That's so interesting. So you bring in his profession as an engineer. He was probably a problem-solver. And as you say, at the moment you met, he didn't have symptoms, really, to palliate. And he was as prepared as he could be for what was likely going to come next. But you use the word 'compassion' in your title, and I want to bring you back to this a little bit. What did you feel in the role as his physician? And I wonder if, as thoughtful as you are in your approach to your patient, if you wondered, if he had a long-term relationship, perhaps, with another physician along the way, or how could you give him what he needed, even if it wasn't exactly what he wanted? [DR. DAVID EINSTEIN] Mm-hmm, yeah. It's really tough coming in at that kind of position, of course. He had a very, very solid relationship with this previous oncologist in a different state, also at a tertiary care academic center. So he was very used to working with that individual and had that trust built up. I'm meeting him, of course, in the worst possible scenario, when he's already gone through everything that we would normally try and even some more off-the-beaten-path treatments. So it's definitely difficult to meet somebody in that position, to gain trust, to build a rapport, to have a long-term relationship to work off of, before you start launching into really difficult end-of-life decision-making, and all the particulars of trying to do what we did, which involves a myriad of details and logistics. And so communicating all of those things, we really had to have this incredibly intense time together to start working on all these things as a shared group. And I think, all along, I felt that I really wanted to emphasize that we were all on the same team. I didn't want him feeling like he had come to me, and that I was in any way shooting down his dreams or not offering anything, from an oncology standpoint. And so time and time again, I really emphasized the fact that, whatever my recommendations are, let's make it about what makes sense for you and what makes sense for your disease, that our common enemy here is the cancer. And that whatever happens, that needs to be the focus. So the focus should not be on the details so much, as how those details get us to the big picture plan. So I think that I really identified with this urge to research and his urge to come up with novel mechanisms. That's what we do as oncologists all the time. But I also had a little bit of trouble getting to understand a guy who was so clearly focused on being in hospital and receiving treatments, even in the situation where I think most of us would feel very uncomfortable with that idea. And so building that understanding took longer, and I think, ultimately, led to a little bit of misunderstanding as things went on. [DR. LIDIA SCHAPIRA] As we about the end, first of all, it sounds like, for you, this felt like climbing Everest. And that's what you say in your essay, and that you certainly were deeply engaged in an active relationship. And then the treatment doesn't work, and he dies. He dies, fortunately, without an aggressive attempt at resuscitation. But then the end leaves you, I think, with a bit of a sour taste, in that there is no final parting with the family or expression of gratitude. Tell us a little bit about how you felt about that and how you've managed to think about it, with a little bit more time. [DR. DAVID EINSTEIN] Yeah, so all along this process, there were really just so many hurdles, quite a large team that I was working with. And a lot of people expressing doubts and frustrations of their own about how much work this was and how quickly it all had to happen. So I pushed through those things as much as I could. And I explained everything that was going on behind the scenes to the patient and his family. And I wanted them not to bend over backwards and thank us for all these efforts. I think it was much more important that he just feel like he had some degree of control and understanding of the situation in an otherwise very out of control situation. So as we got to the end, we had some, obviously, very serious conversations in the ICU and, ultimately, worked on how to plan for his survivors and how to treat symptoms at the end. And we had such an incredibly intense relationship this entire time, where we were constantly in phone and email touch about all of these hurdles that we worked through together. And when you get that email in the morning, saying your patient died overnight, of course, I rushed into the hospital, tried to see if anyone's still around. But by that point, everyone had gone home. And I was actually never able to make contact with them again. I usually like to give a family a couple of days, of course, since it's such an intense time. And I did my best to reach out and leave it very open-ended, that I would love to talk if it made any sense to them, but certainly no pressure. But really what I wanted to reconnect with them about was this incredibly intense experience and how they perceived that that might have helped or not helped him feel like he had been well cared for at the end of his illness. And it's very odd, as the physician, to go from an intense relationship to 0 relationship. And it makes it, I think, a little bit tougher as you go forward to say, was I doing right by this patient? What should I learn for the next experience? [DR. LIDIA SCHAPIRA] David, that was of a beautiful summary. And I'm sorry we need to end it there. We could go on talking so much longer. Thank you for sending the essay. That was Dr. David Einstein, sharing his thoughts on his essay, "Compassion and Compassionate Use." Join me next time for another conversation about the art of oncology. Until next time, thank you for listening to this JCO's Cancer Stories-- The Art of Oncology podcast. If you enjoyed what you heard today, don't forget to give us a rating or review on Apple Podcasts, or wherever you listen. While you're there, be sure to subscribe so you never miss an episode of JCO's Cancer Stories-- The Art of Oncology podcast. This is just one of many of ASCO's podcasts. You can find all of the shows at podcast.asco.org.

Dr. Shiva Ghaed is a California-licensed Clinical Psychologist, currently working for the Department of Mental Health in the Naval Medical Center San Diego healthcare system (Marine Corps Recruit Depot). Dr. Ghaed provides group and individual therapy to active duty patients in the catchment area, maintains ongoing involvement in academia and research, and has served as a voting member on the Institutional Review Board for NMCSD. Dr. Ghaed’s clinical experience includes several years of training and specialization in the Veterans Affairs Healthcare Systems of San Diego and Los Angeles. She completed a Postdoctoral Fellowship at the San Diego VA, specializing in anxiety disorders, non-combat trauma, and combat Posttraumatic Stress Disorder in Operation Enduring Freedom (OEF)/Operation Iraqi Freedom (OIF) veterans. Dr. Ghaed is a member of the American Psychological Association, and strives to maintain competency and excellence as a therapist and professional in her field. In 2015, she was presented with the Associate Master Clinician Award. Oct 1, 2017, Dr. Ghaed’s love of country music took her to Route 91 on the night of the shooting in Las Vegas and she, along with many others, witnessed the horror of that night as people around her were shot and killed. She found purpose and meaning in surviving the massacre, and made it her mission to give back to her community and help guide other Route 91 survivors in their healing. One week following the shooting, Dr. Ghaed launched a free weekly support group for survivors and their family and friends. She posted weekly therapy-based articles specifically catered to and witnessing the Route 91 community recovery process. Her goal is to help people better cope with the traumatic aftermath through education and support, and with the hope of preventing the development of PTSD. A website was created, www.route91therapy.com, to allow public access to these documents, and this information has been disseminated to the Route 91 community across the United States and Canada. In April, 2018, Dr. Ghaed was honored with the Citizens of Courage Award by the San Diego District Attorney’s Office, and the National Hero Award by the American Red Cross (Metro New York). There are still many people who have not connected to care or who do not have adequate social support or healthcare. Dr. Ghaed’s strong belief that healthcare is a basic human right, her faith in the resiliency of the human spirit, and her sense of obligation to serving others fuels a mission of destigmatizing mental illness through knowledge and awareness. In honor of the 1-year anniversary of the Las Vegas massacre (on Oct 1, 2018), Dr. Ghaed released her book, Route 91: Healing from Mass Violence and Trauma for free download https://route91therapy.com/route-91-book . The book documents her experience surviving the massacre, as well as the journey of recovery since then, for her and her Route 91 community. She hopes that her book will provide insight into the process of recovering from mass violence, expected reactions, barriers to recovery, and tools to heal. Furthermore, her teachings are applicable to a broader audience who may suffer from anxiety, depression, or other types of trauma. For anyone that has survived a traumatic event, you can find MANY resources on Dr. Shiva’s site: https://route91therapy.com/ If you need help finding resources contact Dr Shiva through her website: https://route91therapy.com/contact-us To find a Therapist in your area: https://www.psychologytoday.com/us/therapists To find an online counselor: www.talkspace.com https://suicidepreventionlifeline.org provides 24/7, free and confidential support for people in distress, prevention and crisis resources for you or your loved ones, and best practices for professionals.    

Our guest today is Dr. Duane Mitchell, the Phyllis Kottler Friedman Professor in the Department of Neurosurgery at the University of Florida College of Medicine. He’s also the co-director of the university’s Preston A. Wells Jr. Center for Brain Tumor Therapy and Director of the Brain Tumor Immunotherapy Program. Duane and Dawn have been friends since their days at Duke University where they served on the Institutional Review Board together. Duane got his medical degree and doctorate at Duke and then joined the faculty, where he spent the next decade before moving to the University of Florida in 2013. Duane and his team at Florida are among the world leaders in the uphill battle to find ways to treat glioblastoma, an aggressive form of brain cancer that affects about 13,000 Americans annually. It’s the disease that recently took the life of Senator John McCain.  People who are diagnosed with glioblastoma typically live for less than two years. Show notes: [00:03:00] Duane explains the story behind his “quote of the week” tradition, where every Monday morning he share’s a quote with his colleagues in his research group. [00:03:43] Ken asks if it is true that one of Duane’s favorite quotes comes from Mark Twain: “I have never let my schooling interfere with my education.” [00:04:13] Dawn asks if it is true that by the sixth grade Duane had decided he was going to become a doctor. [00:04:52] Duane talks about his decision to attend Rutgers College. [00:05:37] Duane explains how reading Stephen Rosenberg’s book “The Transformed Cell” heavily impacted him during his time at Rutgers. [00:06:43] Dawn mentions that she and Duane met at Duke University, and how this almost didn’t happen because Duane was originally going to attend another university for med school. [00:07:55] Dawn explains that after receiving his MD and Ph.D. from Duke, Duane went on to serve in numerous faculty positions for the next 12 years. During this time, Duane became known as a trailblazer in the application and research of immunotherapy for cancer, particularly brain tumors. Dawn asks Duane for an overview of the role that immunotherapy plays in the treatment of brain tumors. [00:09:30] Duane explains how in 2013 he joined the faculty at the University of Florida and managed to bring his entire team from Duke with him. [00:10:47] Duane has acquired considerable clinical and translational research experience as a principle investigator on seven first-in-human protocols through FDA approved clinical trials. Dawn points out that at Florida, Duane and his team offer unique clinical options for adult and pediatric malignant brain tumor patients. She asks Duane to explain, in depth, the work that he and his do at Florida. [00:12:11] Duane gives an overview of the types of brain tumor and what some of the more common tumor types are. [00:14:09] Dawn asks why Duane chose to specialize in glioblastoma, or GBM, an aggressive form of brain cancer that kills 15,000 Americans eachyear. [00:15:16] Ken asks what characteristics of GBM make those particular types of tumors so difficult to treat. [00:16:17] Duane talks about the standard of care for these malignant brain tumors. [00:18:36] Dawn asks if immunotherapy is a stand-alone approach for treating brain tumors, or if it is administered in conjunction with standard therapy. She goes on to asks if changes to the immune system through radiation or chemotherapy have a negative effect on immunotherapy. [00:21:20] Dawn asks if recent findings about the nervous system’s immune system, and the new-found interconnectedness between the glymphatic system and the lymphatic system impact immunotherapy approaches for brain tumors. [00:23:02] Ken asks how the immune system is naturally equipped to fight cancer. [00:25:36] Dawn explains that the (PD)-1/PD-L1 pathway, otherwise known as Programmed Cell Death, is an immune resistance mechanism that tumor cells exhibit to ...

For our May Narrative Medicine Rounds, we welcome Sandra Soo-Jin Lee, Ph.D., who is the Chief of the Division of Ethics and faculty in the Department of Medical Humanities and Ethics at Columbia University. Dr. Lee is a medical anthropologist with extensive experience leading empirical bioethics research that focuses on the sociocultural and ethical dimensions of emerging genomic technologies. Dr. Lee will speak about "Metaphors, Diversity and Trust in Communicating Precision Medicine." Before coming to Columbia, Dr. Lee taught for nearly two decades at the Stanford Center for Biomedical Ethics and in the Program in Science, Technology and Society at Stanford University. She leads studies on the governance and use of biospecimens and patient data in research and the ethics of inclusion and categorizing diversity in human genetic variation research and translational genomics. Her projects include The Ethics of Inclusion: Diversity in Precision Medicine Research; Beyond Consent: Patient Preferences for Governance of Use of Clinical Samples and Data; and Social Networking and Personal Genomics: Implications for Health Research. Dr. Lee is a Hastings Center Fellow and has served as Chairperson of the Institutional Review Board at the Cancer Prevention Institute of California and on the NIH/NHGRI Coriell Consultation and Oversight Committee of the International Haplotype Map. She currently serves on both the Scientific Advisory and Bioethics Boards of the Kaiser Permanente National Research Biobank, the NIH/NHGRI Genomics and Society Working Group and on the editorial board of Narrative Inquiry in Bioethics. Dr. Lee received her undergraduate degree in Human Biology from Stanford University and her doctorate from the Joint Program in Medical Anthropology at the University of California, Berkeley and University of California, San Francisco. Her postdoctoral fellowship training in Bioethics and Genetics was in the School of Medicine at Stanford University. Narrative Medicine Rounds are monthly rounds on the first Wednesday of the month during the academic year hosted by the Division of Narrative Medicine in the Department of Medical Humanities and Ethics at Columbia University Medical Center. These events are free and open to the public.

This week bad at sports presents a event on When Projects Depart presented at Hauser and Wirth by our partners BFAMFAPhD. Event 5: When Projects Depart   What practices might we develop to honor the departure of a project?  For example, where do materials go when they are no longer of use, value, or interest?   Millet Israeli and Lindsay Tunkl   Millet Israeli is a psychotherapist who focuses on the varied human experience of loss.  She works with individuals and families struggling with grief, illness, end of life issues, anticipatory loss, and ambiguous loss.  Her approach integrates family systems theory, cognitive restructuring, mindfulness, and trauma informed care. Millet enjoys creating and exploring photography and poetry, and both inform her work with her clients. Millet holds a BA in psychology from Princeton, a JD from Harvard Law School, an MSW from NYU and is certified in bioethics through Montefiore. She sits on an Institutional Review Board for Human Subjects Research at Weill Cornell.   Lindsay Tunkl is a conceptual artist and writer using performance, sculpture, language, and one-on-one encounters to explore subjects such as the apocalypse, heartbreak, space travel, and death. Tunkl received an MFA in Fine art and an MA in Visual + Critical Studies from CCA in San Francisco (2017) and a BFA from CalArts In Los Angeles (2010). Her work has been shown at the Hammer Museum, LA, Southern Exposure, SF, and The Center For Contemporary Art, Santa Fe. She is the creator of Pre Apocalypse Counseling and the author of the book When You Die You Will Not Be Scared To Die. Upcoming Event: Group Agreements What group agreements are necessary in gatherings that occur at residencies, galleries, and cultural institutions today? Friday 4/19 from 6-8pm Sarah Workneh, Laurel Ptak, and Danielle Jackson RSVP https://www.eventbrite.com/e/making-and-being-group-agreements-tickets-54315175151?utm_source=eb_email&utm_medium=email&utm_campaign=new_event_email&utm_term=viewmyevent_button   BFAMFAPhD Making and Being is a multi-platform pedagogical project that offers practices of contemplation, collaboration, and circulation in the visual arts. Making and Being is a book, a series of videos, a deck of cards, and an interactive website with freely downloadable content created by authors Susan Jahoda and Caroline Woolard with support from Fellow Emilio Martinez Poppe and BFAMFAPhD members Vicky Virgin and Agnes Szanyi. Bio BFAMFAPhD is a collective that employs visual and performing art, policy reports, and teaching tools to advocate for cultural equity in the United States. The work of the collective is to bring people together to analyze and reimagine relationships of power in the arts. BFAMFAPhD received critical acclaim for Artists Report Back (2014), which was presented as the 50th anniversary keynote at the National Endowment for the Arts and was exhibited at the Brooklyn Museum, the Museum of Art and Design, Gallery 400 in Chicago, Cornell University, and the Cleveland Institute of Art. Their work has been reviewed in The Atlantic, the New York Times, the Washington Post, the New Yorker, Andrew Sullivan’s The Dish, WNYC, and Hyperallergic, and they have been supported by residencies and fellowships at the Queens Museum, Triangle Arts Association, NEWINC and PROJECT THIRD at Pratt Institute. BFAMFAPhD members Susan Jahoda and Caroline Woolard are now working on Making and Being, a multi-platform pedagogical project which offers practices of collaboration, contemplation, and social-ecological analysis for visual artists.

In this episode of The Dr. Hedberg Show, I interview Dr. Terry Wahls in a discussion about how to heal Multiple Sclerosis.  We had an excellent discussion about how she overcame Multiple Sclerosis, her research into MS, The Wahls Protocol Diet, the causes of MS, how the gut and the microbiome influences autoimmune disease, the Paleo diet compared to the Wahls Protocol and much more. If you have MS or know someone who does, please share this episode and transcript of the interview below.  It may be the turning point for you or a loved one by following The Wahls Protocol. Dr. Hedberg: Well, welcome everyone to the Dr. Hedberg Show. This is Dr. Hedberg, and I'm very excited today to have Dr. Terry Wahls on the show. So, Dr. Wahls is a Clinical Professor of Medicine at the University of Iowa. She's the author of the book, "The Wahls Protocol: How I Beat Progressive MS Using Paleo Principles and Functional Medicine," and also the cookbook, "The Wahls Protocol Cooking for Life: The Revolutionary Modern Paleo Plan to Treat All Chronic Autoimmune Conditions." You can learn more about her work from her website. It's terrywahls.com. That's terrywahls.com. And she hosts "The Wahls Protocol Seminar" every August where anyone can learn how to implement the protocol with ease and success. And she's on social media. You can find her on Facebook, Terry Wahls, M.D., Instagram, Dr. Terry Wahls, and on Twitter, @TerryWahls. And you can learn more about her MS clinical trials by reaching out to her team via this email, it's msdietstudy@healthcare.uiowa.edu, and I will paste that link and e-mail on drhedberg.com in case you wanna contact her that way. So, Dr. Wahls, welcome to the show. Dr. Wahls: Hey. Thank you so much for having me. Dr. Hedberg: Great. So, just for the people out there who don't really know your story, can you tell us a little bit about what you went through and your MS story? Dr. Wahls: Sure. So, I'm an academic internal medicine doc, very conventionally trained and conventionally practicing, being very skeptical of diets, supplements, complementary and alternative medicine. But God has a way of teaching us, so in 2000, I was diagnosed with relapsing-remitting multiple sclerosis on the basis of a history of dim vision 13 years earlier, and a new problem with my left leg. I had lesions in my spinal cord. So, I knew I wanted to see the best people in the country, take the newest drugs, and so I went to the Cleveland Clinic and saw their best people, took the newest drugs, and steadily declined. I'd had one relapse in the next year involving my right hand. And I continued to gradually decline. By 2003, I had declined enough that I now needed a tilt-recline wheelchair. I took Mitoxantrone. I adopted, yeah, actually the year earlier, the paleo diet after being a vegetarian for 20 years, but as I had already mentioned, I did continue to decline and was in the wheelchair, took Mitoxantrone, continued to decline, then took Tysabri, continued to decline, then was placed on CellCept. And at that point, in 2004, it's quite clear to me that I'm likely to become bedridden, quite possibly demented, and quite possibly suffer from intractable pain related to poorly controlled trigeminal neuralgia. And so, I start reading the basic science again, and I began experimenting using a variety of supplements targeting my mitochondria. And what I discovered is that my fatigue is somewhat less, the speed of my decline is slowed, and I'm really immensely grateful because now my docs have told me I have secondary progressive MS, that there's no more spontaneous recoveries, and so I'm grateful just to slow my decline. Now, the summer of '07, I'm so weak I cannot sit up anymore. I have a zero gravity chair, where my knees are higher than my nose. A staff, resident clinic's there. I work in the Institutional Review Board reviewing research protocols that way. And I have another chair at home.

Dr. Mary Ruwart joins me to talk about self-ownership, medical freedom and the seemingly radical idea of the Separation of Church and State. You can follow her work at: http://www.ruwart.com Dr. Ruwart is a very warm, compassionate and intelligent person who truly believes, as I do, that the principles of individual liberty are the best ideas to organize a society upon. We discuss her most recent book "Death By Regulation." http://www.ruwart.com/product/death-regulation Dr. Ruwart makes the compelling case that the increased FDA regulatory authority granted by the 1962 Drug Amendment Act has led to a stifling of innovation, the massive increase in drug costs and the death of nearly 15,000,000 Americans. http://www.ruwart.com/blog/a-1962-law-slowed-drug-development-changing-it-could-slash-drug-prices.html I've bashed big pharma many times in the past and our conversation made me reconsider redirecting the blame more toward the FDA and those laws that give it the authority which has created the modern drug industry. We also discuss the concept of self-ownerships. This is the concept that you own yourself and that when the government tells you what you can and can't do they are violating this basic individual right. Her take is that libertarianism or the repeat for individual rights is the compassionate way to organize society. Dr. Ruwart was an early follower of Ayn Rand but felt there was something missing from her interpretation of individualism. She believes that humans have an innate need for other humans and that this is on the genetic level. And that charity and compassion are comparable with livery and help the person whose doing the helping more than those being helped. Love thy neighbor is still valid today as it was 2000 years ago. Dr. Ruwart also has a fascinating take on how government regulations are in fact a form of non-voluntary human experimentation that violates the ethical framework meant to protect people from being experimented upon without their consent. She is on the board of Institutional Review Board that is tasked with helping to insure that informed consent and certain guidelines are followed for human testing. http://www.ruwart.com/blog/an-ethicist-asks-is-regulation-unethical-human-experimentation.html During our conversation we also talk about the idea of The Separation of Medicine and State just as there is the Separation of Church and State. We discusses how both are based upon the same principle as self-ownership. The topic of the opioid crisis came up as well. Dr. Ruwart shared her personal story of how she had to watch her sister with cancer needlessly suffering due to issues with the red tape around pain medicine. She also related how her sister became so ill and was in so much pain they decided together to go to Dr. Kervokian to end her life. A very powerful story and highlights how we need to change the laws to allow individual to exercise their inherent right of self determination and have painless, effective means of ending one's own life. We had a great conversation about how we would all benefit from getting government out of your healthcare choices, the compassionate ethical side of libertarianism and how it's a matter of life and death when it comes to your medical freedom. Thanks for tuning in. Let us know what you think about Medical Freedom. Brad Miller The Chronically Human Podcast Sent from ProtonMail Mobile

Duncan catches up with two of the members of BFAMFAPhD for a chat about the upcoming event series, which for those of you in NYC starts friday with MAKING & BEING.   Conversations about Art & Pedagogy co-presented by BFAMFAPhD & Pioneer Works, hosted by Hauser & Wirth, with media partners Bad at Sports and Eyebeam.   image credit... BFAMFAPhD, Making and Being Card Game, print version, 2016-2018, photograph by Emilio Martinez Poppe. Full details below... ____________________________   Hauser & Wirth   BFAMFAPhD is a collective that employs visual and performing art, policy reports, and teaching tools to advocate for cultural equity in the United States.   Pioneer Works is a cultural center dedicated to experimentation, education, and production across disciplines.   Contemporary art talk without the ego, Bad at Sports is the Midwest's largest independent contemporary art podcast and blog. Eyebeam is a platform for artists to engage society’s relationship with technology.   Access info:   The event is free and open to the public. RSVP is required through www.hauserwirth.com/events.   The entrance to Hauser & Wirth Publishers Bookshop is at the ground floor and accessible by wheelchair. The bathroom is all-gender. This event is low light, meaning there is ample lighting but fluorescent overhead lighting is not in use. A variety of seating options are available including: folding plastic chairs and wooden chairs, some with cushions.   This event begins at 6 PM and ends at 8 PM but attendees are welcome to come late, leave early, and intermittently come and go as they please. Water, tea, coffee, beer and wine will be available for purchase. The event will be audio recorded. We ask that if you do have questions or comments after the event for the presenters that you speak into the microphone. If you are unable to attend, audio recordings of the events will be posted on Bad at Sports Podcast after the event.   Parking in the vicinity is free after 6 PM. The closest MTA subway station is 23rd and 8th Ave off the C and E. This station is not wheelchair accessible. The closest wheelchair accessible stations are 1/2/3/A/C/E 34th Street-Penn Station and the 14 St A/C/E station with an elevator at northwest corner of 14th Street and Eighth Avenue. ____________________________ "While knowledge and skills are necessary, they are insufficient for skillful practice and for transformation of the self that is integral to achieving such practice.” - Gloria Dall’Alba BFAMFAPhD presents a series of conversations that ask: What ways of making and being do we want to experience in art classes? The series places artists and educators in intimate conversation about forms of critique, cooperatives, artist-run spaces, healing, and the death of projects. If art making is a lifelong practice of seeking knowledge and producing art in relationship to that knowledge, why wouldn’t students learn to identify and intervene in the systems that they see around them? Why wouldn't we teach students about the political economies of art education and art circulation? Why wouldn’t we invite students to actively fight for the (art) infrastructure they want, and to see it implemented?   The series will culminate in the launch of Making and Being, a multi-platform pedagogical project that offers practices of collaboration, contemplation, and social-ecological analysis for visual artists. Making and Being is a book, a series of videos, a deck of cards, and an interactive website with freely downloadable content created by authors Susan Jahoda and Caroline Woolard with support from Fellow Emilio Martinez Poppe and BFAMFAPhD members Vicky Virgin and Agnes Szanyi.   ____________________________   SCHEDULE ____________________________ Modes of Critique   What modes of critique might foster racial equity in studio art classes at the college level?   Friday 1/18 from 6-8pm Billie Lee and Anthony Romero of the Retooling Critique Working Group Respondent: Eloise Sherrid, filmmaker, The Room of Silence   Billie Lee is an artist, educator, and writer working at the intersection of art, pedagogy, and social change. She holds a BFA from the Rhode Island School of Design, an MFA from Yale University, and is a doctoral candidate at the University of Hawai‘i at Mānoa in American Studies. She has held positions at the Queens Museum, the Yale University Art Gallery, Doris Duke Foundation for Islamic Art, University of New Haven, University of Hawai‘i at Mānoa, and is currently an Assistant Professor of Art History at Hartford Art School.   Anthony Romero is an artist, writer, and organizer committed to documenting and supporting artists and communities of color. Recent projects include the book-length essay The Social Practice That Is Race, written with Dan S. Wang and published by Wooden Leg Press, Buenos Dias, Chicago!, a multi-year performance project commissioned by the Museum of Contemporary Art Chicago and produced in collaboration with Mexico City based performance collective, Teatro Linea de Sombra. He is a co-founder of the Latinx Artists Retreat and is currently a Professor of the Practice at The School of the Museum of Fine Arts at Tufts University.   Judith Leemann is an artist, educator, and writer whose practice focuses on translating operations through and across distinct arenas of practice. A long-standing collaboration with the Boston-based Design Studio for Social Intervention grounds much of this thinking. Leemann is Associate Professor of Fine Arts 3D/Fibers at the Massachusetts College of Art and Design and holds an M.F.A. in Fiber and Material Studies from the School of the Art Institute of Chicago. Her writings have been included in the anthologies Beyond Critique (Bloomsbury, 2017), Collaboration Through Craft (Bloomsbury, 2013), and The Object of Labor: Art, Cloth, and Cultural Production (School of the Art Institute of Chicago and MIT Press 2007). Her current pedagogical research is anchored by the Retooling Critique working group she first convened in 2017 to take up the question of studio critique’s relation to educational equity.   The Retooling Critique Working Group is organized by Judith Leemann and was initially funded by a Massachusetts College of Art and Design President's Curriculum Development Grant.   Eloise Sherrid is a filmmaker and multimedia artist based in NYC. Her short viral documentary, "The Room of Silence," (2016) commissioned by Black Artists and Designers (BAAD), a student community and safe space for marginalized students and their allies at Rhode Island School of Design, exposed racial inequity in the critique practices institutions for arts education, and has screened as a discussion tool at universities around the world.   __________________________   Artist-Run Spaces   How do artists create contexts for encounters with their projects that are aligned with their goals?   Friday 2/1 from 6-8pm Linda Goode-Bryant, Heather Dewey-Hagborg, and Salome Asega   Linda Goode-Bryant is the Founder and President of Active Citizen Project and Project EATS. She developed Active Citizen Project while filming the 2004 Presidential Elections and developed Project EATS during the 2008 Global Food Crisis. She is also the Founder and Director of Just Above Midtown, Inc. (JAM), a New York City non-profit artists space. Linda believes art is as organic as food and life, that it is a conversation anyone can enter. She has a Masters of Business Administration from Columbia University and a Bachelor of Arts Degree in painting from Spelman College and is the recipient of a Guggenheim Fellowship and a Peabody Award.   Heather Dewey-Hagborg is a transdisciplinary artist who is interested in art as research and critical practice. Heather has shown work internationally at events and venues including the World Economic Forum, the Shenzhen Urbanism and Architecture Biennale and PS1 MOMA. Her work is held in public collections of the Centre Pompidou, the Victoria and Albert Museum, and the New York Historical Society, and has been widely discussed in the media, from the New York Times to Art Forum. Heather is also a co-founder of REFRESH, an inclusive and politically engaged collaborative platform at the intersection of Art, Science, and Technology.   Salome Asega is an artist and researcher based in New York. She is the Technology Fellow in the Ford Foundation's Creativity and Free Expression program area, and a director of POWRPLNT, a digital art collaboratory in Bushwick. Salome has participated in residencies and fellowships with Eyebeam, New Museum, The Laundromat Project, and Recess Art. She has exhibited and given presentations at the 11th Shanghai Biennale, Performa, EYEO, and the Brooklyn Museum. Salome received her MFA from Parsons at The New School in Design and Technology where she also teaches.   ____________________________   Building Cooperatives   What if the organization of labor was integral to your project?   Friday 2/22 from 6-8pm Members of Meerkat Filmmakers Collective and Friends of Light   Meerkat Media Collective is an artistic community that shares resources and skills to incubate individual and shared creative work. We are committed to a collaborative, consensus-based process that values diverse experience and expertise. We support the creation of thoughtful and provocative stories that reflect a complex world. Our work has been broadcast on HBO, PBS, and many other networks, and screened at festivals worldwide, including Sundance, Tribeca, Rotterdam and CPH:Dox. Founded as an informal arts collective in 2005 we have grown to include a cooperatively-owned production company and a collective of artists in residence.   Friends of Light develops and produces jackets woven to form for each client.  We partner with small-scale fiber producers to source our materials, and with spinners to develop our yarns.    We construct our own looms to create pattern pieces that have complete woven edges (selvages) and therefore do not need to be cut. The design emerges from the materials and from methods developed to weave two dimensional cloth into three dimensional form. Each jacket is the expression of the collective knowledge of the people involved in its creation. Our business is structured as a worker cooperative and organized around cooperative principles and values. Friends of light founding members are Mae Colburn, Pascale Gatzen, Jessi Highet and Nadia Yaron.   ____________________________   Healing and Care (OFFSITE EVENT)   How do artists ensure that their individual and collective needs are met in order to dream, practice, work on, and return to their projects each day?   Thursday 2/28 from 6-8pm Adaku Utah and Taraneh Fazeli NOTE this event will be held at 151 West 30th Street  # Suite 403, New York, NY 10001   Adaku Utah was raised in Nigeria armed with the legacy of a long line of freedom fighters, farmers, and healers. Adaku harnesses her seasoned powers as a liberation educator,healer, and performance ritual artist as an act of love to her community. Alongside Harriet Tubman, she is the co-founder and co-director of Harriet's Apothecary, an intergenerational healing collective led by Black Cis Women, Queer and Trans healers, artists, health professionals, activists and ancestors. For over 12 years, her work has centered in movements for radical social change, with a focus on gender, reproductive, race, and healing justice. Currently she is the Movement Building Leadership Manager with the National Network for Abortion Funds. She is also a teaching fellow with BOLD (Black Organizing for Leadership and Dignity) and Generative Somatics.   Taraneh Fazeli is a curator from New York. Her multi-phased traveling exhibition “Sick Time, Sleepy Time, Crip Time: Against Capitalism’s Temporal Bullying” deals with the politics of health. It showcases the work of artists and groups who examine the temporalities of illness and disability, the effect of life/work balances on wellbeing, and alternative structures of support via radical kinship and forms of care. The impetus to explore illness as a by-product of societal structures while also using cultural production as a potential place to re-imagine care was her own chronic illnesses. She is a member of Canaries, a support group for people with autoimmune diseases and other chronic conditions.   ____________________________   When Projects Depart   What practices might we develop to honor the departure of a project?  For example, where do materials go when they are no longer of use, value, or interest?   Thursday 3/14 from 6-8pm Millet Israeli and Lindsay Tunkl   Millet Israeli is a psychotherapist who focuses on the varied human experience of loss.  She works with individuals and families struggling with grief, illness, end of life issues, anticipatory loss, and ambiguous loss.  Her approach integrates family systems theory, cognitive restructuring, mindfulness, and trauma informed care. Millet enjoys creating and exploring photography and poetry, and both inform her work with her clients. Millet holds a BA in psychology from Princeton, a JD from Harvard Law School, an MSW from NYU and is certified in bioethics through Montefiore. She sits on an Institutional Review Board for Human Subjects Research at Weill Cornell.   Lindsay Tunkl is a conceptual artist and writer using performance, sculpture, language, and one-on-one encounters to explore subjects such as the apocalypse, heartbreak, space travel, and death. Tunkl received an MFA in Fine art and an MA in Visual + Critical Studies from CCA in San Francisco (2017) and a BFA from CalArts In Los Angeles (2010). Her work has been shown at the Hammer Museum, LA, Southern Exposure, SF, and The Center For Contemporary Art, Santa Fe. She is the creator of Pre Apocalypse Counseling and the author of the book When You Die You Will Not Be Scared To Die.   ____________________________   Group Agreements   What group agreements are necessary in gatherings that occur at residencies, galleries, and cultural institutions today?   Friday 4/19 from 6-8pm Sarah Workneh, Laurel Ptak, and Danielle Jackson   Sarah Workneh has been Co-Director at Skowhegan for nine years leading the educational program and related programs in NY throughout the year, and oversees facilities on campus. Previously, Sarah worked at Ox-Bow School of Art as Associate Director. She has served as a speaker in a wide variety of conferences and schools. She has played an active role in the programmatic planning and vision of peer organizations, most recently with the African American Museum of Philadelphia. She is a member of the Somerset Cultural Planning Commission's Advisory Council (ME); serves on the board of the Colby College Museum of Art.   Laurel Ptak is a curator of contemporary art based in New York City. She is currently Executive Director & Curator of Art in General. She has previously held diverse roles at non-profit art institutions in the US and internationally, including the Guggenheim Museum (New York), MoMA PS. 1 Contemporary Art Center (New York), Museo Tamayo (Mexico City), Tensta Konsthall (Stockholm) and Triangle (New York). Ptak has organized countless exhibitions, public programs, residencies and publications together with artists, collectives, thinkers and curators. Her projects have garnered numerous awards, fellowships, and press for their engagement with timely issues, tireless originality, and commitment to rigorous artistic dialogue.   Danielle Jackson is a critic, researcher, and arts administrator. She is currently a visiting scholar at NYU’s Center for Experimental Humanities.  As the co-founder and former co-director of the Bronx Documentary Center, a photography gallery and educational space, she helped conceive, develop and implement the organization’s mission and programs.  Her writing and reporting has appeared in artnet and Artsy. She has taught at the Museum of Modern Art, International Center of Photography, Parsons, and Stanford in New York, where she currently leads classes on photography and urban studies.   ____________________________ Open Meeting for Arts Educators and Teaching Artists   How might arts educators gather together to develop, share, and practice pedagogies that foster collective skills and values?   Friday 5/17 from 6-8pm Facilitators: Members of the Pedagogy Group   The Pedagogy Group is a group of educators, cultural workers, and political organizers who resist the individualist, market-driven subjectivities produced by mainstream art education. Together, they develop and practice pedagogies that foster collective skills and values. Activities include sharing syllabi, investigating political economies of education, and connecting classrooms to social movements.Their efforts are guided by accountability to specific struggles and by critical reflection on our social subjectivities and political commitments.   ____________________________   Book Launch: Making and Being: A Guide to Embodiment, Collaboration and Circulation in the Visual Arts   What ways of making and being do we want to experience in art classes?   Friday 10/25 from 6-8pm Stacey Salazar in dialog with Caroline Woolard, Susan Jahoda, and Emilio Martinez Poppe of BFAMFAPhD   Stacey Salazar is an art education scholar whose research on teaching and learning in studio art and design in secondary and postsecondary settings has appeared in Studies in Art Education, Visual Arts Research, and Art Education Journal. In 2015 her research was honored with the National Art Education Association Manuel Barkan Award. She holds a Doctorate of Education in Art and Art Education from Columbia University Teachers College and currently serves as Associate Dean of Graduate Studies at the Maryland Institute College of Art, where she was a 2013 recipient of the Trustee Fellowship for Excellence in Teaching.   BFAMFAPhD is a collective that employs visual and performing art, policy reports, and teaching tools to advocate for cultural equity in the United States. The work of the collective is to bring people together to analyze and reimagine relationships of power in the arts. Susan Jahoda is a Professor in Studio Arts at the University of Amherst, MA; Emilio Martinez Poppe is the Program Manager at Fourth Arts Block (FABnyc) in New York, NY; Caroline Woolard is an Assistant Professor of Sculpture at The University of Hartford, CT. Supporting this series at Hauser and Wirth for Making and Being are BFAMFAPhD collective members Agnes Szanyi, a Doctoral Student at The New School for Social Research in New York, NY and Vicky Virgin, a Research Associate at The Center for Economic Opportunity in New York, NY. Making and Being is a multi-platform pedagogical project that offers practices of collaboration, contemplation, and social-ecological analysis for visual artists. Making and Being is a book, a series of videos, a deck of cards, and an interactive website with freely downloadable content created by authors Susan Jahoda and Caroline Woolard with support from Fellow Emilio Martinez Poppe and BFAMFAPhD members Vicky Virgin and Agnes Szanyi.